<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Interdiscip Perspect Infect Dis</journal-id><journal-id journal-id-type="publisher-id">IPID</journal-id><journal-title>Interdisciplinary Perspectives on Infectious Diseases</journal-title><issn pub-type="ppub">1687-708X</issn><issn pub-type="epub">1687-7098</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19259328</article-id><article-id pub-id-type="pmc">2648619</article-id><article-id pub-id-type="doi">10.1155/2008/626827</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Interactions of the Intestinal Epithelium with the Pathogen and  the Indigenous Microbiota: A Three-Way Crosstalk</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Srikanth</surname><given-names>C. V.</given-names></name><xref ref-type="aff" rid="I1"><sup>1,2</sup></xref><xref ref-type="aff" rid="I2"/></contrib><contrib contrib-type="author"><name><surname>McCormick</surname><given-names>Beth A.</given-names></name><xref ref-type="aff" rid="I1"><sup>1,2</sup></xref><xref ref-type="aff" rid="I2"/><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Pediatric Gastroenterology and Nutrition, Mucosal Immunology Laboratories, Massachusetts General Hospital, Charlestown, MA 02129, USA</aff><aff id="I2"><sup>2</sup>Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA</aff><author-notes><corresp id="cor1">*Beth A. McCormick: <email>mccormic@helix.mgh.harvard.edu</email></corresp><fn fn-type="other"><p>Recommended by Vincent B. Young</p></fn></author-notes><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>29</day><month>10</month><year>2008</year></pub-date><volume>2008</volume><elocation-id>626827</elocation-id><history><date date-type="received"><day>2</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>8</day><month>8</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 C. V. Srikanth and B. A. McCormick.</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>The mucosal surfaces of the gastrointestinal tract harbor a vast number of commensal microbiota that have coevolved with the host, and in addition display one of the most complex relationships with the host. This relationship affects several important aspects of the biology of the host including the synthesis of nutrients, protection against infection, and the development of the immune system. On the other hand, despite the existence of several lines of mucosal defense mechanisms, pathogenic organisms such as Shigella and Salmonella have evolved sophisticated virulence strategies for breaching these barriers. The constant challenge from these pathogens and the attempts by the host to counter them set up a dynamic equilibrium of cellular and molecular crosstalk. Even slight perturbations in this equilibrium may be detrimental to the host leading to severe bacterial infection or even autoimmune diseases like inflammatory bowel disease. Several experimental model systems, including germ-free mice and antibiotic-treated mice, have been used by various researchers to study this complex relationship. Although it is only the beginning, it promises to be an exciting era in the study of these host-microbe relationships.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTION</title><p>A mature human gut harbors a vast number of bacterial residents referred to asthe commensal microflora or more recently as &#x0201c;microbiota.&#x0201d; It has beenestimated that this microbiota is made up of more than 10<sup>14</sup> individualbacteria comprising over 500 different species [<xref ref-type="bibr" rid="B121">1</xref>]. Notably, the composition of themicrobiota is individual specific and the type of species residing in the gastrointestinal(GI) tract varies with the host organism's age, diet, and health status [<xref ref-type="bibr" rid="B46">2</xref>]. In fact, the total number of microbesin the human GI tract far exceeds (&#x0003e;10&#x02013;100 times) thesum of all our somatic and germ cells. The biological outcome of this vast andcomplex population of microbes is that their genes (termed the microbiome)synthesize about 100 times more proteins than the somatic cells of their host [<xref ref-type="bibr" rid="B57">3</xref>].</p><p>Notsurprisingly, the human intestine is more densely populated with microorganismsthan any other organ and is a site where they exert a strong influence on humanbiology. This is because the intestinalmucosa serves as the primary border between the immune system and the externalenvironment, and in addition plays a central role in host-commensal florainteractions. Accumulating evidence indicates that the gut microbiota isinstrumental in supporting energy metabolism and immune function of the host. More recent studies suggest that the commensal microbiota play an importantrole in the development of numerous conditions, including obesity [<xref ref-type="bibr" rid="B65">4</xref>, <xref ref-type="bibr" rid="B134">5</xref>], diabetes [<xref ref-type="bibr" rid="B19">6</xref>], nonalcoholic fatty liver disease [<xref ref-type="bibr" rid="B32">7</xref>], inflammatory bowel disease [<xref ref-type="bibr" rid="B130">8</xref>], and perhaps cancer [<xref ref-type="bibr" rid="B27">9</xref>]. Unfortunately, the immense complexityof gut flora together with its highly complicated interactions with intestinalepithelium makes it a recalcitrant system to study. Although largelyunexplored, our gut microbiota plays an intricate and under-appreciated pivotalrole for our health and well-being. In this review we will discuss newdevelopments in the field that highlight the cellular and molecular basis ofthe crosstalk between the host, the commensal microbiota, and pathogenicbacteria in a healthy as well as a diseased GI tract.</p></sec><sec sec-type="section" id="sec2"><title>2. ROLE OF THE MICROBIOTA INTHE GASTROINTESTINAL TRACT</title><p>Themicroflora of the intestinal microenvironment as a unit provides importantprotective, metabolic, and trophic functions. Resident bacteria serve a centralline of resistance to colonization by exogenous microbes, and thus assist inpreventing the potential invasion of the intestinal mucosa by an incomingpathogen. This protective function is known as the barrier effect or colonizationresistance and serves a number of important roles. For instance, adherentnonpathogenic bacteria can often prevent attachment and subsequent entry ofsuspected pathogens into epithelial cells, as well as compete for nutrientavailability. The commensal microbiotaalso helps maintain GI nutrient homeostasis by administering and consuming allresources. For example, dietarynutrients are absorbed by the gut and together with various nonnutrientcompounds produced by the microbiota are cometabolize by host enzymes, such ascytochrome P450 and conjugating enzymes in the liver [<xref ref-type="bibr" rid="B96">10</xref>]. The resulting metabolites that arederived from both host and microbial processes are returned to the gut by thebile for further metabolism or excretion [<xref ref-type="bibr" rid="B54">11</xref>]. This mutual and beneficial relationshiphelps to dampen unwanted overproduction of nutrients, which could potentiallysupport intrusion of microbial competitors with a potential pathogenic outcomefor the host [<xref ref-type="bibr" rid="B48">12</xref>].</p><p>Quiteremarkably, an absence of intestinal bacteria is associated with reduction inmucosal cell turnover, vascularity, muscle wall thickness, motility, baselinecytokine production, digestive enzyme activity, and defective cell-mediatedimmunity [<xref ref-type="bibr" rid="B69">13</xref>]. Indeed, comparative studies ingerm-free and conventional animals have established that the intestinalmicroflora is essential for the development and function of the mucosal immunesystem during early life, a process that is now known to be important tooverall immunity in adults. For example, it has been well established that thenumber of intraepithelial and lamina propria T cells is lower in germ-freeanimals, a feature that is reversed upon the restoration of the normal flora [<xref ref-type="bibr" rid="B20">14</xref>]. Likewise, levels of secretory IgA arelow in the intestine of germ-free animals but are markedly increased uponintestinal colonization of the commensal bacterium, <italic>Bacteroides thetaiotamicron</italic> [<xref ref-type="bibr" rid="B45">15</xref>]. Furthermore, the intimate relationshipbetween the commensal microbiota and the intestinal epithelium are involved inshaping the memory mechanisms of systemic immunity, such as oral tolerance. This was initially recognized by the discovery that the systemic response to aspecific pathogen can be abrogated after ingesting the antigen; this effectcontinues for several months in conventionally colonized mice, whereas ingerm-free mice systemic unresponsiveness persists for only a few days [<xref ref-type="bibr" rid="B88">16</xref>]. Therefore, the innate immune systemdiscriminates between potential pathogens from the commensal microbiota byinducing tolerance to microbial epitopes. This, in turn, dampens responses tocommonly encountered foodstuffs and other environmental antigens. Collectively,these examples help to illustrate the important concept that the commensalmicrobiota profoundly influence the development of the gut mucosal immunesystem and are essential in preventing exogenous pathogen intrusion.</p><p>The intestinal microflora also makesimportant metabolic contributions by producing vitamin K, folate, and short-chainfatty acids (a major energy source for enterocytes), and mediates the breakdownof dietary carcinogens as well [<xref ref-type="bibr" rid="B46">2</xref>, <xref ref-type="bibr" rid="B13">17</xref>]. Perhaps the major metabolic function of the colonicmicroflora is the fermentation of nondigestible carbohydrates. Thesenondigestible carbohydrates include large polysaccharides (i.e., resistantstarches, pectins, cellulose), some oligosaccharides that escape digestion, aswell as unabsorbed sugars and alcohols. The primary metabolic endpoint of suchfermentation is the generation of short-chain fatty acids (acetate,proprionate, butyrate). A fundamental role of short-chain fatty acids oncolonic physiology is their trophic effect on the intestinal epithelium. Therefore, short-chain fatty acids appear to play an essential role in thecontrol of epithelial cell proliferation and differentiation in the colon. Recent studies have also shown effects of butyrate on intestinal barrierfunction [<xref ref-type="bibr" rid="B104">18</xref>]. Moreover, it has been shown that commensal bacterial can modulate geneexpression in the host in order to create a sustainable environment forthemselves, while at the same time prevent the growth of other competitivebacteria within the intestinal ecosystem [<xref ref-type="bibr" rid="B45">15</xref>].</p><p>For the host to thrive and produce moregut residents, the gut microbial ecosystem must be functionally stable overtime despite the internal dynamics of the community. Constituent bacteria areexpected to have a high degree of functional redundancy between species, sothat the loss of one lineage does not adversely impact the homeostatic balanceof the intestinal microenvironment [<xref ref-type="bibr" rid="B140">19</xref>]. While it is unclear how the selectivepressures, microbial community dynamics, and the intestinal microenvironmentshape the genome and subsequent functions of members of the gut microbiota,there are some exciting new developments in the field. For example, Gordon etal. have introduced the provocative concept that the evolution of the gutmicrobiome also likely plays a significant role in shaping the evolution ofhumans [<xref ref-type="bibr" rid="B140">19</xref>]. This tenet is founded on experiments inwhich this team of investigators sequenced the genomes of two gut-dwellingBacteroidetes and compared their genomes to the genomes of other bacteria thatlive both inside and outside of the human body. Quite remarkably, theydiscovered that lateral gene transfer, mobile genetic elements, and geneamplification play an important role in affecting the ability of theBacteroidetes to vary their cell surface, sense their environment, and harvestnutrient resources present in the distal intestine [<xref ref-type="bibr" rid="B140">19</xref>]. Importantly, these findings lay theconceptual groundwork to suggest that adaptation to the gut ecosystem is adynamic process that includes acquisition of genes from other microorganisms,and further underscores the significance of considering the evolution humansfrom the perspective of the evolution of the microbiome [<xref ref-type="bibr" rid="B140">19</xref>, <xref ref-type="bibr" rid="B64">20</xref>].</p></sec><sec sec-type="section" id="sec3"><title>3. RESTRICTING PATHOGENS AND COMMENSALFROM INVADING BEYOND THE MUCOSAL SURFACE</title><p>Thehost is protected from potentially harmful enteric microorganisms by thephysical and chemical barriers created by the intestinal epithelium that areprimarily comprised of absorptive villus enterocytes [<xref ref-type="bibr" rid="B72">21</xref>]. The apical surface of the enterocytesare highly differentiated structures consisting of rigid, closely packedmicrovilli whose membranes contain stalked glycoprotein enzymes [<xref ref-type="bibr" rid="B87">22</xref>, <xref ref-type="bibr" rid="B124">23</xref>]. In addition, the tips of enterocyte microvilli arecoated with a 400&#x02013;500 nm thickmeshwork referred to as the filamentous brush border glycocalyx [<xref ref-type="bibr" rid="B51">24</xref>] and is composed of highly glycosylatedtransmembrane mucins [<xref ref-type="bibr" rid="B76">25</xref>, <xref ref-type="bibr" rid="B77">26</xref>]. The intestinal epithelial barrier is also composed ofenteroendocrine cells, goblet cells, and Paneth cells. Microfold (M) cells arealso present in the follicle-associated epithelia where they represent amorphologically distinct epithelial cell type whose primary functionis in the transport of macromolecules, particles, and microorganismsfrom the lumen to underlying lymphoid tissue [<xref ref-type="bibr" rid="B37">27</xref>, <xref ref-type="bibr" rid="B95">28</xref>]. Intercellular junctional complexes that are composed oftight junctions, adherens junctions, and desomosomes maintain the integrity ofthe epithelial barrier. The most apical components of the junctional complexare the epithelial tight junctions, which are highly regulated and serve tocreate a semipermeable diffusion barrier between individual cells (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>). Collectively, these features facilitate the intestinal epithelium to act as aphysical barrier to prevent unwanted bacteria from gaining access to the host.</p><p>The intestinal epithelium alsoprovides a unique surface that is armed with a bounty of specialized cells thatproduce mucus, antimicrobial peptides, and antimicrobial molecules, whichtogether form the front line of defense against pathogenic microorganisms (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>). The mucus layer is secreted by the goblet cells and this layer overliesthe intestinal epithelium to create a physical blockade against offendingenteric microbial pathogens. For example, it has been demonstrated thatsecreted mucus acts as a barrier to <italic>Yersinia enterocolitica</italic> [<xref ref-type="bibr" rid="B74">29</xref>], rhesus rotavirus [<xref ref-type="bibr" rid="B25">30</xref>], and <italic>Shigellaflexneri</italic> [<xref ref-type="bibr" rid="B99">31</xref>]. The commensal microbiota has also beenfound to regulate the production of intestinal mucins, which consequentlyinhibits the adherence of numerous pathogenic bacteria to intestinal epithelialcells [<xref ref-type="bibr" rid="B70">32</xref>&#x02013;<xref ref-type="bibr" rid="B127">34</xref>]. Paneth cells areanother important cell type that are involved in intestinal defense againstpotential harmful pathogenic bacteria. These cells are present at the base ofthe crypt of Lieberk&#x000fc;hn [<xref ref-type="bibr" rid="B101">35</xref>] and have been shown to produce a numberof antimicrobial peptides. In addition, the gastrointestinal expression ofantimicrobial peptides is evolutionarily conserved [<xref ref-type="bibr" rid="B143">36</xref>], and to date, <italic>&#x003b1;</italic>-defensins (HD), <italic>&#x003b2;</italic>-defensins (hBD), and cathelicidins have beenidentified in humans [<xref ref-type="bibr" rid="B66">37</xref>]. Paneth cells also produce a number ofantimicrobial molecules, including lysozyme, phospholipase A<sub>2</sub>, andangiogenin-4 (reviewed in [<xref ref-type="bibr" rid="B66">37</xref>]). Therefore, it is inferred by numerousstudies that Paneth cells are able to control the bacterial ecosystem (<xref ref-type="table" rid="tab1">Table 1</xref>).</p><p>Angiogenin-4 is expressed mainly in thesmall intestine, cecum, and colon and acts on Gram-positive bacteria [<xref ref-type="bibr" rid="B47">49</xref>, <xref ref-type="bibr" rid="B97">50</xref>]. However, most antimicrobial peptides expressed bymammalian epithelial cells are members of peptide families that mediatenonoxidative microbial cell killing by phagocytes [<xref ref-type="bibr" rid="B97">50</xref>]. These amphipathic molecules interact with and lyse bacterial membranes [<xref ref-type="bibr" rid="B138">55</xref>]. Defensinsgenerally possess a broad range of antimicrobial activity (<xref ref-type="table" rid="tab1">Table 1</xref>). Inparticular, human intestinal defensin-5 has been shown to kill <italic>Listeria monocytogenes</italic>, <italic>E. coli,</italic> and <italic>Candida albicans</italic> [<xref ref-type="bibr" rid="B106">40</xref>]. Additional evidence supporting acritical role for defensins in vivowas demonstrated in a study utilizing human defensin-5 transgenic mice; thesemice exhibited marked resistance to oral challenge with virulent <italic>Salmonella enterica</italic> serovar Typhimurium (<italic>S. typhimurium</italic>) [<xref ref-type="bibr" rid="B115">39</xref>]. Theintestinal epithelial cells also express another class of antimicrobialpeptide, the cathelicidins (LL-37/Cap18), in which a cathelin domain is linkedto a peptide with antimicrobial activity [<xref ref-type="bibr" rid="B63">56</xref>]. LL-37 is expressed within theepithelial cells located at the surface and upper crypts of normal human colon. Although little or no expression is seen within the deeper colonic crypts orwithin epithelial cells of the small intestine, studies in mice have determinedthese molecules to be protective against bacterial pathogens [<xref ref-type="bibr" rid="B110">47</xref>]. Interestingly, the expression of thesefactors, unlike the angiogenins, is not induced by the presence of pathogenicbacteria but rather their secretion is triggered by the commensal microbiotaand/or their derivatives. A recent addition to this growing list of intestinalantimicrobial includes RegIII<italic>&#x003b3;</italic>, which has been shown to be toxic toGram-positive bacteria [<xref ref-type="bibr" rid="B24">52</xref>]. RegIII<italic>&#x003b3;</italic> is a C-type lectin that binds to thecarbohydrate moiety of bacterial cell wall constituent, petidoglycan. Recentstudies have further shown that the expression of RegIII<italic>&#x003b3;</italic> is strongly dependent upon the presence of thegut microflora since in germ-free mice RegIII<italic>&#x003b3;</italic> expression is severely repressed [<xref ref-type="bibr" rid="B17">53</xref>] (<xref ref-type="table" rid="tab1">Table 1</xref>).</p><p>The intestinal epithelium also provides asurface where the host can sense the microbial microenvironment in order toelicit an appropriate defense response by releasing an array of signalingmolecules (i.e., chemokines and cytokines). These molecules then trigger the recruitment ofleukocytes to initiate an early inflammatory response. Paradoxically, however,although continuously exposed to Gram-positive and Gram-negative bacteria andtheir products (i.e., lipopolysaccarhide (LPS), peptidoglycan, and lipoprotein)the normal healthy intestinal mucosa maintains a mechanism ofhyporesponsiveness to the lumenal microbiota and their products. Exaggeratedinflammatory responses in the absence of pathogenic bacteria would be otherwisedeleterious [<xref ref-type="bibr" rid="B22">57</xref>, <xref ref-type="bibr" rid="B23">58</xref>]. Accordingly, the normal intestinal epithelial hostdefenses are able to accurately interpret the complex microbial environment inorder to discriminate between permanently established commensal microbes andepisodic pathogens.</p><p>At the core of this strategy theendogenous microbiota all share &#x0201c;self&#x0201d; signature molecules termedmicrobe-associated molecular patterns [<xref ref-type="bibr" rid="B52">59</xref>]. However, upon infection of a pathogenicorganism, the host immune response is activated by the specific recognition of&#x0201c;nonself&#x0201d; molecular structures known as pathogen-associated molecular patterns. The epithelial cells are able to sense the microenvironment within the gut bymeans of pattern recognition receptors (PRRs) that include Toll-like receptors(TLRs) and nucleotide-binding oligimerization domain (NOD) proteins [<xref ref-type="bibr" rid="B34">38</xref>, <xref ref-type="bibr" rid="B53">60</xref>&#x02013;<xref ref-type="bibr" rid="B105">63</xref>]. TLRs are evolutionary conserved and are characterized byan extracellular leucine rich repeat (LRR) domain (involved in ligandrecognition), as well as an intracellular Toll/interleukin-1 receptor-likedomain (involved in proinflammatory signal transduction) [<xref ref-type="bibr" rid="B53">60</xref>, <xref ref-type="bibr" rid="B1">64</xref>&#x02013;<xref ref-type="bibr" rid="B141">66</xref>]. In addition, two NOD proteins (NOD1 and NOD2) function asintracellular sensors of bacterial products in the induction of an inflammatoryresponse [<xref ref-type="bibr" rid="B53">60</xref>, <xref ref-type="bibr" rid="B1">64</xref>&#x02013;<xref ref-type="bibr" rid="B109">67</xref>].</p><p>ThesePRRs recognize bacterial factors, such as LPS, lipoproteins, flagellin,unmethylated-CpG DNA, and a large number of other specific components. Regulation of the expression and the specific location of TLRs and NODs inintestinal epithelial cells fosters efficient immune recognition of thecommensal microflora and maintains a delicate balance; permitting a basal levelof signaling events to proceed, while at the same time restraining innateimmune responses. For instance in a healthy intestine, epithelial cells expressvery little or no TLR2, TLR4, and CD14, and as a result minimizes therecognition of commensal LPS [<xref ref-type="bibr" rid="B2">68</xref>, <xref ref-type="bibr" rid="B86">69</xref>]. TLR5, which recognizes bacterial flagellin, has beenreported to be expressed exclusively on the basolateral surfaces of theepithelial cells. This TLR is ideally positioned to detect its ligand,translocated flagellin [<xref ref-type="bibr" rid="B39">70</xref>]. Moreover TLR3, TLR7, TLR8, and TLR9 areexpressed in the intracellular endosomal compartments [<xref ref-type="bibr" rid="B85">71</xref>]. These intracellular PRRs would notordinarily encounter luminal commensal bacteria or those attached to the apicalsurface of intestinal epithelial cells but are well positioned to recognizepathogenic bacteria that actively breach the epithelial barrier. As anadditional measure, commensal bacteria have the ability to induce theexpression of intestinal alkaline phosphatase, which not only dephosphorylatesdietary lipids but also dephosphorylates the LPS of commensal flora resultingin reduced toxicity in mammals [<xref ref-type="bibr" rid="B10">72</xref>].</p><p>Nonpathogenic microorganisms may also beable to selectively attenuate the NF-kB pathway as mechanism of intestinalimmune tolerance. Neish et al. initially reported that colonization of a humanmodel intestinal epithelium with certain strains of nonpathogenic bacteriacould dampen the host cell responses to subsequent proinflammatory challengesby blocking the proinflammatory/antiapoptic NF-<italic>&#x003ba;</italic>B pathway [<xref ref-type="bibr" rid="B92">73</xref>]. This effect is mediated by the inhibition of I<italic>&#x003ba;</italic>B-<italic>&#x003b1;</italic> ubiquitination, which prevents regulated I<italic>&#x003ba;</italic>B-<italic>&#x003b1;</italic> degradation, NF-<italic>&#x003ba;</italic>B nuclear translocation, and subsequentactivation of proinflammatory/antiapoptic genes. I<italic>&#x003ba;</italic>B-<italic>&#x003b1;</italic> ubiquitination is catalyzed by E3-SCF<sup><italic>&#x003b2;</italic>&#x02212;TrCP</sup> ubiquitin ligase [<xref ref-type="bibr" rid="B139">74</xref>], which is regulated via covalent modification of thecullin-1 subunit by the ubiquitin-like protein NEDD8 [<xref ref-type="bibr" rid="B100">75</xref>, <xref ref-type="bibr" rid="B107">76</xref>]. Recently, it was determined that the interaction ofnonpathogenic bacteria with epithelial cells results in the rapid loss ofneddylated Cul-1 and consequent repression of the NF-<italic>&#x003ba;</italic>B pathway [<xref ref-type="bibr" rid="B28">77</xref>]. Collectively, this set of observationsunderscores the ability of intestinal bacterial communities to influenceeukaryotic processes, and perhaps more specifically demonstrates inflammatorytolerance of the mammalian intestinal epithelia.</p></sec><sec sec-type="section" id="sec4"><title>4. HOW PATHOGENS OVERCOMETHE EPITHELIAL BARRIER</title><p>Asdescribed above, the intestinal epithelium has evolved a rather formidablefortress to guard against microbial invasion. However, through a process ofcoevolution, potential harmful enteric microorganisms have evolved counterstrategies to hijack the cellular molecules and signaling pathways of the hostto become potentially pathogenic. As an initial step in the infection process,certain enteric pathogens target specific epithelial cell structures, includingglycoproteins and glycolipids, which serve as receptors for bacterialattachment [<xref ref-type="bibr" rid="B122">78</xref>]; thus, enabling them to exploit theunderlying signal transduction pathway. Other strategies utilized by invadingenteric pathogens, such as <italic>S. </italic><italic>typhimurium</italic> and <italic>Shigella flexneri</italic> have evolved a sophisticated strategythatdirects the entry of the enteric pathogen into intestinal epithelial cells. This process requires the expression of a bacterial type III protein secretion system (TTSS), the function of which is to deliver a set of effector proteins into the host cell [<xref ref-type="bibr" rid="B38">79</xref>&#x02013;<xref ref-type="bibr" rid="B144">81</xref>]. These effector proteins co-opt host cell signaltransduction cascades as a clever means of subverting normal host cellprocesses by triggering a marked rearrangement of the hostcytoskeleton. This entry mechanism termed bacterial mediated endocytosis drivesbacterial entry and facilitates the pathogen to cross the epithelial barrier aswell as to induce a proinflammatory response [<xref ref-type="bibr" rid="B38">79</xref>&#x02013;<xref ref-type="bibr" rid="B144">81</xref>].</p><p>Thelatter step in this process can be achieved by direct cytotoxic injury,intracellular migration, disruption of the epithelial tight junctions, orindirectly by inducing neutrophil infiltration. Although several bacterialpathogens have been able to modulate epithelial tight junctions totheir own advantage, the direct interaction of a bacterial virulencefactor on component proteins of the tight junction has been proposedonly in a few instances [<xref ref-type="bibr" rid="B123">82</xref>]. It is well documented that anumber of enteric pathogens perturb the intestinal epithelialbarrier and impact TER or paracellular permeability, most often withan alteration in the arrangement of tight junctional componentproteins by mechanisms that are unique for different pathogens [<xref ref-type="bibr" rid="B123">82</xref>]. For example, <italic>Clostridium difficile</italic> toxins A and B enhance epithelialcell permeability by disrupting actin microfilaments within theperijunctional ring [<xref ref-type="bibr" rid="B43">83</xref>], and enteropathogenic <italic>Escherichia coli</italic> disrupt the epithelialbarrier by the phosphorylation of myosin light chains [<xref ref-type="bibr" rid="B142">84</xref>]. With respect to <italic>S. typhimurium</italic>, in vitro models of infection haverevealed an alteration of epithelial permeability and loss ofbarrier function, which involves rapid changes in both tight junctionpermeability and transcellular conductance [<xref ref-type="bibr" rid="B58">85</xref>, <xref ref-type="bibr" rid="B108">86</xref>]. Recent studies further indicate that the <italic>Salmonella</italic> effector protein SigD (also called SopB), which is encoded in <italic>Salmonella</italic> pathogenicity island-1 (SPI-1), is able to elicit a reduction inepithelial barrier function, perhaps via activation of PKC [<xref ref-type="bibr" rid="B15">87</xref>]. Also, the effector proteins SopB, SopE,SopE2, and SipA are necessary to disrupt the epithelial barrier andalter the distribution of at least some tight junction proteins [<xref ref-type="bibr" rid="B16">88</xref>, <xref ref-type="bibr" rid="B133">89</xref>]. Suchperturbations in the components of the tight junction lead to enhancedbacterial translocationand infiltration of neutrophils across the intestinal barrier. Therefore, theability to regulate the molecular composition of the tight junctionsfacilitates the pathogenecity of <italic>S. typhimurium</italic> by fostering its uptake and distribution within the host (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>) [<xref ref-type="bibr" rid="B58">85</xref>].</p><p>				<italic>S. flexneri</italic> has adistinct mode of pathogenesis that involves entry into colonic epithelialcells from the basolateral surface [<xref ref-type="bibr" rid="B89">90</xref>], thereby requiring itsrelocation from the lumenal to the underlying surface of theepithelium. This translocation event has historically beenattributed to the uptake and transport by M cells [<xref ref-type="bibr" rid="B116">91</xref>]. However, it has since been established that <italic>Shigellae</italic> are also capable of altering components of thetight junctional complex, allowing the bacteria to traverse theparacellular space to reach the basolateral surface; an event thatalso decreases barrier function [<xref ref-type="bibr" rid="B114">92</xref>]. Once at the basolateral surface, <italic>Shigellae</italic> rapidly invade anddisseminate through the epithelium, causing a further decrease inbarrier function [<xref ref-type="bibr" rid="B114">92</xref>&#x02013;<xref ref-type="bibr" rid="B14">94</xref>] through the action of a TTSS system andadditional proteins encoded on a large virulence plasmid [<xref ref-type="bibr" rid="B14">94</xref>&#x02013;<xref ref-type="bibr" rid="B120">97</xref>].</p><p>Entericpathogens cause a variety of diseases in humans but one undeniable symptom isthe presentation of gastroenteritis. Some bacterial enteric infections arecharacterized by disruption of the normal movement of electrolytes and wateracross the epithelium, which is converted from a state of net fluid absorptionto one of net fluid secretion [<xref ref-type="bibr" rid="B111">98</xref>]. Secretory diarrhea, as a result ofepithelial chloride secretion, has long been regarded as a host defensemechanism. This is based on the notion that increased fluid and electrolytemovement into the gut lumen helps to inhibit adherence of pathogenic organismsby &#x0201c;flushing&#x0201d; them from the body. However, it could also be argued that theinduction of pathogen-induced diarrhea is a way to ensure transmission to newhosts, and thus pathogenic fitness [<xref ref-type="bibr" rid="B42">99</xref>]. These ideas are not mutually exclusiveand secretory diarrhea may be advantageous to both host and pathogen.</p><p>Pathogenic bacteria cause diarrhea bymultiple mechanisms. <italic>Vibrio cholerae</italic> reside in the lumen of the small intestine and produce toxins, which alter ionabsorption and/or secretion [<xref ref-type="bibr" rid="B3">100</xref>, <xref ref-type="bibr" rid="B128">101</xref>]. Other bacteria such as <italic>Shigella</italic> and enteroinvasive <italic>E. coli</italic> invade anddestroy the colonic epithelium leading to dysentery [<xref ref-type="bibr" rid="B102">102</xref>]. More recently pathogenic <italic>E. coli</italic> have been shown to increasechloride ion secretion from intestinal epithelia by upregulating the expressionof the receptor for the neuropeptide galanin 1 [<xref ref-type="bibr" rid="B12">103</xref>]. Rotavirus, another important cause ofdiarrhea in infants, induces this condition by activating the enteric nervoussystem [<xref ref-type="bibr" rid="B67">104</xref>, <xref ref-type="bibr" rid="B135">105</xref>].</p><p>A large influx of neutrophils (PMNs) intothe mucosa and lumen from the underlying vasculature is a significant featureof intestinal bacterial infections [<xref ref-type="bibr" rid="B135">105</xref>, <xref ref-type="bibr" rid="B136">106</xref>]. During infection of epithelial cells by enteric pathogenssuch as <italic>S. typhimurium</italic> and <italic>S. flexneri</italic>, IL-8 is synthesized andsecreted baslaterally. Such basolateral IL-8 release imprints subepithelial matriceswith long-lived haptotactic gradients that serve to guide neutrophils throughthe lamina propria to a subepithelial position [<xref ref-type="bibr" rid="B82">107</xref>]. However, basolateral IL-8 release isinsufficient to induce the migration of neutrophils across the intestinalepithelium, suggesting that the production of other inflammatory mediators,whose release would probably be polarized apically, is important for theexecution of this step in the inflammatory pathway [<xref ref-type="bibr" rid="B82">107</xref>, <xref ref-type="bibr" rid="B81">108</xref>]. In support of this contention, Kucharzik et al. recently developed adouble transgenic mouse model with the ability to induce human IL-8 expressionrestricted to the intestinal epithelium [<xref ref-type="bibr" rid="B60">109</xref>]. The results from this transgenic model showed thatalthough acute induction of IL-8 in the intestinal epithelium is sufficient totrigger neutrophil recruitment to the lamina propria, additional signals arerequired for neutrophil transepithelial migration and mucosal tissue injury. Indeed, recent evidence suggests that the eicosanoid, hepoxilin A<sub>3</sub>,is secreted apically and is responsible for the final step of neutrophiltransepithelial migration into the gut lumen [<xref ref-type="bibr" rid="B84">110</xref>, <xref ref-type="bibr" rid="B90">111</xref>]. This process isquite complex as distinct signaling pathways mediate <italic>S. typhimurium</italic> invasion, induction of CXCL8 secretion, andinduction of hepoxilin A<sub>3</sub> secretion [<xref ref-type="bibr" rid="B90">111</xref>&#x02013;<xref ref-type="bibr" rid="B80">113</xref>].</p><p>The ability of <italic>Salmonella</italic> serotypes to elicit PMN transmigration in vitro correlates with theirability to cause diffuse enteritis (defined histologically as transepithelialmigration of neutrophils), but not typhoid fever in humans [<xref ref-type="bibr" rid="B83">114</xref>]. Moreover, large-scale PMN transepithelialmigration causes decreased barrier function [<xref ref-type="bibr" rid="B91">115</xref>]. Studies exploring the mechanism underlying the release of HXA<sub>3</sub> duringinfection with <italic>S. typhimurium</italic> revealed the involvement of the <italic>S. typhimurium</italic> type III secreted effector protein, SipA [<xref ref-type="bibr" rid="B62">116</xref>]. The <italic>S. typhimurium</italic> effector protein, SipA, promotes a lipid signal transduction cascadethat recruits an ADP-ribosylation factor 6 guanine nucleotide exchange factor(such as ARNO) to the apical plasma membrane. ARNO facilitates ADP-ribosylationfactor 6 activation at the apical membrane, which in turn, stimulatesphospholipase D recruitment to and activity at this site. The phospholipase Dproduct, phosphatidic acid, is metabolized by a phosphohydrolase intodiacylglycerol, which recruits cytosolic protein kinase C (PKC)-alpha tothe apical membrane. Through a process that is less understood, activatedPKC-alpha phosphorylates downstream targets that are responsible for theproduction and apical release of HXA<sub>3</sub>, which drives transepithelialneutrophil movement [<xref ref-type="bibr" rid="B29">117</xref>].</p></sec><sec sec-type="section" id="sec5"><title>5. PROTOTYPICAL INTERACTIONSBETWEEN PATHOGENIC BACTERIA ANDCOMMENSAL MICROBIOTA</title><p>Thereare ample lines of evidence to support the emerging concept that a change inthe composition of the commensal microbiota alters the intestinalmicroenvironment making this niche vulnerable to pathogenic insult. In thissection we discuss examples to illustrate the remarkable crosstalk between thehost, its intestinal microbiota, and potential pathogenic bacteria.</p><p>Ithas been well documented that <italic>S. typhimurium</italic> causes a systemic (typhoid fever) infection in mice while inhumans this enteric pathogen causes gastroenteritis. However, Barthel et al. discoveredthat pretreatment of C57BL/6 mice with streptomycin, an antibiotic that killsfacultative anaerobes, followed by infection with a streptomycin-resistantstrain of <italic>S. </italic><italic>typhimurium</italic> produced a robust intestinal inflammatory response [<xref ref-type="bibr" rid="B9">118</xref>]. Such enteritis is primarily characterized by inflammationin the cecum, and also presents with several of the typical pathologicalhallmarks of acute <italic>Salmonella</italic>-inducedgastroenteritis in humans, including PMN infiltration and epithelial cellerosion. This is an intriguing result since the only difference between theuntreated and streptomycin treated mice is the alteration of the commensalflora; thus, demonstrating that the presence of the microflora plays aprotective role against pathogenic invaders. This study also substantiates thelong-standing finding of Barrow and Tucker who found that pretreatment of achicken's cecum with three different strains of <italic>E. coli</italic> significantly reduced infection with <italic>Salmonella</italic> as compared to untreated animals [<xref ref-type="bibr" rid="B8">119</xref>]. Additionally, Hudault et al. (2001)determined that the presence of a single species of <italic>E. coli</italic> in the gut could restrict the infection of S <italic>. typhimurium</italic> as compared to its germ-freecounterpart [<xref ref-type="bibr" rid="B49">120</xref>].</p><p>Morerecently, Stecher et al. used the <italic>S. typhimurium</italic> colitis model to investigate competition between an entericpathogen and the host microbiota [<xref ref-type="bibr" rid="B129">121</xref>]. This group found that inflammatory responses induced by <italic>S. typhimurium</italic> led to profoundperturbations in the composition of the commensal microbiota as determined by16S rRNA. The inflammatory host responses induced by <italic>S. typhimurium</italic> not only changed the microbiota composition but alsosuppressed its growth, thereby, overcoming colonization resistance. In contrast,an avirulent <italic>Salmonella</italic> mutantdefective in triggering inflammation was unable to overcome colonizationresistance. These results raise an interesting point in that perhaps theintestinal inflammation induced by <italic>S. typhimurium</italic> might be a crucial event in order to overcome colonizationresistance. In this respect, triggering the host's immune defense may shift thebalance between the protective microbiota and the pathogen to favor thepathogen. The idea that the intestinal microbiota can be altered by invadingpathogens is further supported by Lupp et al. who found that host-mediatedinflammation in response to an infectious agent induced alterations in thecolonic community that not only resulted in the elimination of a subset ofindigenous microbiota but also led to the growth of the Enterobacteriaceaefamily [<xref ref-type="bibr" rid="B68">122</xref>]. Moreover, in children undergoingtreatment for diarrhea, fluctuations in the intestinal microflora were observedfor both rotaviral and nonrotaviral-induced diarrhea [<xref ref-type="bibr" rid="B5">123</xref>]. This phenotype was reversed and thenormal microflora was re-established after about three months of the diseaseepisode. Other studies have investigated the role of the intestinal microbiotaduring infectious disease transmission. In particular, Lawley et al. describe amodel in which persistently infected 129X1/SvJ mice provide a natural model oftransmission. In this model, only a subset of mice termed &#x0201c;supershedders&#x0201d; couldshed high levels of bacteria in their feces. Whereas immunosuppression of theinfected mice did not induce the supershedder phenotype, antibiotic treated micedisplayed a high supershedder phenotype [<xref ref-type="bibr" rid="B61">124</xref>]. Together, these studies suggest thatthe intestinal microbiota plays a critical role in controlling pathogeninfection, disease, and even transmissibility.</p><p>Thereare also examples in which members of the commensal microflora are able tocause disease. This is specifically illustrated by <italic>Enterococcus faecalis</italic>, a prominent member of the GI tractmicrobiota. In a healthy intestine these bacteria behave as a normal resident ofthe intestinal ecosystem. However, in individuals undergoing antibiotictreatment or those who are immunocompromised, <italic>E. faecalis</italic> is able to colonize new niches of the intestinalmicroenvironment as a certain subgroup of this species is antibiotic resistant(<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>). Under such compromised conditions, <italic>E. faecalis</italic> can infect and spread to other sites of the host suchas the bloodstream, urinary tract, and surgical wounds. Not surprisingly, thesubgroup population harboring the antibiotic resistance genes also has geneticelements conferring infectivity and virulence. Furthermore, the genome sequenceof <italic>E. faecalis</italic> strain V583, the mostcausative agent of vancomycin resistant enterococcal infection in America, [<xref ref-type="bibr" rid="B113">125</xref>] was recently reported [<xref ref-type="bibr" rid="B103">126</xref>]. Recent studies have determined that more than 25% of the <italic>E. faecalis</italic> genome is most likelyderived from mobile or foreign DNA, which might have contributed to the rapidacquisition and dissemination of drug resistant strains [<xref ref-type="bibr" rid="B103">126</xref>]. Another example is illustrated by <italic>Clostridium </italic><italic>difficle</italic>, aGram-positive bacterium that can harmlessly inhabit the human intestine. However, certain individuals undergoing antibiotic therapy, as a result oftheir altered intestinal microflora, presented with <italic>C. difficle</italic> infection accompanied with severe intestinal colitis(<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>) [<xref ref-type="bibr" rid="B56">127</xref>].</p><p>Commensalbacteria, such as <italic>Bacteroides fragilis</italic>,may also inhibit other opportunistic members of the intestinal microflora fromcausing disease [<xref ref-type="bibr" rid="B79">128</xref>]. <italic>B. fragilis</italic> is a Gram-negative bacterium that resides in a healthy humanintestine. Normally, this bacterium expresses a surface carbohydrate capsuleknown as polysaccharide A (PSA), which contributes to many beneficialactivities underlying the immune development of the host, including activationof CD4+ T cells, and stimulation of the innate immune responses through TLR2signaling. Mazmanian et al. determined that <italic>B. fragilis</italic> protects the host from <italic>Helicobacterhepaticus</italic>-induced colitis in experimental mice. However, in animalsharboring <italic>B. fragilis</italic> strains that donot express PSA, <italic>H. hepaticus</italic> colonization led to disease and production of proinflammatory cytokines inducedby intestinal immune cells [<xref ref-type="bibr" rid="B79">128</xref>, <xref ref-type="bibr" rid="B78">129</xref>]. Thus, in healthy individuals it appears that PSA from <italic>B. fragilis</italic> is necessary to confer somebeneficial activity. In spite of this, PSA was also found to potentiate theability of <italic>B. fragilis</italic> to causedisease in patients who have a compromised mucosal surface, such aspostsurgical patients. This function is initiated upon submucosal entry of thebacteria during which PSA activates CD4+ T cells leading to abscess formation [<xref ref-type="bibr" rid="B18">130</xref>].</p></sec><sec sec-type="section" id="sec6"><title>6. ROLE OF BACTERIA IN INFLAMMATORYBOWEL DISEASE</title><p>Recent evidence from a variety of investigative avenuesimplicates abnormal host-microbial interactions in the pathogenesis ofinflammatory bowel disease (IBD). In fact, IBDs preferentially occur in thecolon and distal ileum (i.e., locations that contain the highest concentrationsof intestinal bacteria). An important role for microbial agents in thepathogenesis of IBD is inferred by numerous recent studies, which conclude thebacterial flora differs between patients with inflammatory bowel disease (IBD)and healthy individuals. Moreover, accumulating evidence suggests that thecomposition and function of the microbiota in patients suffering with IBD are abnormal.</p><p>Ninety-ninepercent of the gut microbiota in healthy individuals is composed of specieswithin four bacterial divisions: <italic>Firmicutes</italic>, <italic>Bacteroidetes</italic>, <italic>Proeobacteia</italic>, and <italic>Actinobacteria</italic> [<xref ref-type="bibr" rid="B33">131</xref>, <xref ref-type="bibr" rid="B36">132</xref>]. Investigation of the microbial diversity in active IBD isa highly pursued topic of interest and is an area of research still at itsinfancy. In IBD patients, early returns have suggested that there is a decreasein the number of beneficial bacteria, such as <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> spp., and an increase in pathogenic bacteria, such as a <italic>Bacteroides</italic> and <italic>Escherichia </italic><italic>coli</italic> [<xref ref-type="bibr" rid="B36">132</xref>&#x02013;<xref ref-type="bibr" rid="B131">136</xref>]. Such dysbiosis induces a breakdown in the balance betweenputative spp. of protective versus harmful bacteria, and may promoteinflammation. Other studies have shown that there is a decrease in microbialdiversity that accompanies the increased numbers of Enterobacteriaceae,including <italic>E. </italic><italic>coli</italic>, with decreased numbers of <italic>Firmicutes</italic>,and a particular decrease in <italic>Clostridium</italic> species. As convincing as this data is, there is still a lack of evidence todenote whether a specific pathogen is responsible for onsets or relapses of IBD[<xref ref-type="bibr" rid="B36">132</xref>]. Further, the most compelling studiesare derived from animal models. Regardless, a number of organisms have beenimplicated in Crohn's disease, with <italic>Mycobacteriumparatuberculosis</italic> and <italic>E. coli</italic> drawing a great deal of attention [<xref ref-type="bibr" rid="B119">137</xref>].</p><p>Patientswith IBD have higher numbers of mucosa-associated bacteria than control patients[<xref ref-type="bibr" rid="B132">138</xref>], and the generalized or local dysbiosisobserved is due to the presence of low numbers of normal bacteria and highnumbers of unusual bacteria with a decrease in biodiversity. The composition ofthe increased numbers of bacteria attached to the intestinal epithelium of IBDpatients are from diverse genera. <italic>Bacteroidesspp</italic>., in particular, has been identified as a predominate member of theepithelial layer, and in some instances was located intracellularly [<xref ref-type="bibr" rid="B131">136</xref>]. While this remains an intriguing observation, the role of <italic>Bacteroides</italic> in IBD is still unclear. Furthermore, distinct adherent or invasive <italic>E. coli</italic> has been identified in the ileal mucus of patients with Crohn'sdisease, and the involvement of a new potentially pathogenic group of adherentinvasive <italic>E. coli</italic> (AIEC) has beensuggested [<xref ref-type="bibr" rid="B7">139</xref>]. For instance, in studies aimed toassess the predominance of <italic>E. coli</italic> strains associated with the ileal mucosa of Crohn's disease patients, <italic>E. coli</italic> was recovered from 65% ofchronic lesions and from 100% of the biopsies of early lesions. By comparison,3&#x02013;6% of the <italic>E. coli</italic> was recoveredform healthy ileal mucosa. <italic>E. coli</italic> was also abnormally present (50&#x02013;100% of the totalnumber of aerobes and anaerobes) in early and chronic ileal lesions of CDpatients [<xref ref-type="bibr" rid="B30">140</xref>, <xref ref-type="bibr" rid="B94">141</xref>]. These observations were confirmed in a subsequent study inwhich adherent <italic>E. coli</italic> was found in38% of patients with active ileal Crohn's disease [<xref ref-type="bibr" rid="B11">133</xref>]. This study also revealed that thenumber of <italic>E. coli</italic> in situ correlated with the severity of the disease, and that the invasive <italic>E. coli</italic> was also restricted to theinflamed mucosa. Interestingly, the recovered <italic>E. coli</italic> strains were predominantly novel in phylogeny, displayed pathogen-likebehavior in vitro, and expressed virulence factors [<xref ref-type="bibr" rid="B11">133</xref>].</p><p>Itis suspected that the abnormal colonization of the lieal mucosa is largely dueto increased expression of CEACAM6, a receptor for adherent-invasive <italic>E. coli</italic> [<xref ref-type="bibr" rid="B6">142</xref>]. However, Crohn's disease patients also exhibit defectivemicrobial killing mechanisms that result in increased exposure to commensalbacteria. For example, Crohn's disease patients have defective antimicrobialpeptide production, including <italic>&#x003b1;</italic>-defensin 5 in ileal disease and human <italic>&#x003b2;</italic>-defensin 2 in Crohn's colitis [<xref ref-type="bibr" rid="B59">143</xref>, <xref ref-type="bibr" rid="B137">144</xref>]. This is accompanied by functional abnormalities in thekilling of <italic>Bacteroides vulgatus</italic>, <italic>E. coli</italic>, and <italic>Enterococcusfaecalis</italic> [<xref ref-type="bibr" rid="B98">145</xref>]. In addition, NOD2 polymorphisms inCrohn's disease are associated with selective decrease in <italic>&#x003b1;</italic>-defensin production by Paneth cells, as wellas in defective clearance of intracellular pathogens by colonic epithelialcells [<xref ref-type="bibr" rid="B44">146</xref>]. Thus, combined with defectiveantimicrobial peptide function in Crohn's disease the functional changesdescribed above provide a reasonable rationale for the profound increase inmucosally associated Enterobacteriaceae. Also, in light of the alteration inthe composition of the luminal microbiota, it is perhaps not surprising thatCrohn's disease has features that might be the consequence of a microbial process. This is exemplified by the noted infection of Peyer's patches and lymphoidaggregates, and the presence of ulcerations, microabscesses, fissures, fistulas, granulomas,and lymphangitis [<xref ref-type="bibr" rid="B119">137</xref>].</p><p>As evidence accumulates to suggest thatdysbiosis in IBD patients induces a breakdown in the balance between putativespp. of protective versus harmful bacteria, one potential new method ofintervention lies in the modulation of the enteric flora. Indeed, currentstudies suggest that probiotics might offer an alternative or adjuvant approachto conventional IBD therapies by altering the intestinal microflora and, inturn, modulating the host immune system. Probiotics are defined as living foodsupplements or components of bacteria that have a beneficial effect on humanhealth. Indeed, probiotic activity has been associated with <italic>Lactobacillus</italic>, <italic>Bifidobacteria</italic>, <italic>Streptococcus</italic>, <italic>Enterococcus</italic>, nonpathogenic <italic>E. coli</italic>, and <italic>Saccharomyces bourlardii</italic> [<xref ref-type="bibr" rid="B125">147</xref>, <xref ref-type="bibr" rid="B126">148</xref>].</p><p>Probioticsupplements may balance the indigenous microflora in IBD patients. A growingbody of literature supports this emerging concept, which suggests thatprobiotics have therapeutic effects in ulcerative colitis, Crohn's disease andpouchitis [<xref ref-type="bibr" rid="B125">147</xref>, <xref ref-type="bibr" rid="B126">148</xref>]. The rationale for employing probiotics in the treatment ofIBD is underscored by the proposed pathogenic role of the intestinal microflorain this disease. Numerous studies support the notion that introduction ofprobiotics to the GI tract can alter the enteric microflora in IBD patients,which in turn has a profound effect on intestinal defense mechanisms, including(i) inhibiting microbial pathogenic growth, (ii) increasing epithelial cell tightjunctions and permeability, (iii) modulating the immune response of theintestinal mucosa, (iv) increasing the secretion of antimicrobial products, and(iv) eliminating pathogenic antigens [<xref ref-type="bibr" rid="B41">149</xref>&#x02013;<xref ref-type="bibr" rid="B31">151</xref>]. Thus, such broad mechanistic effects of probiotics mayexplain the beneficial effects observed.</p><p>Probioticpreparations are primarily based on a variety of lactic acid bacteria(lactobacilli, bifidobacteria, and streptococci), which under healthyconditions are normal and important components of the commensal microbiota. Inaddition, probiotic mixtures often contain some nonpathogenic bacteria thatinclude <italic>E. coli</italic>, enterococci, oryeast (<italic>Saccharomyces bourlardii</italic>) [<xref ref-type="bibr" rid="B21">152</xref>]. Probiotic strains also need to satisfyimportant criteria. First, probiotics must be safe and tested for human use [<xref ref-type="bibr" rid="B41">149</xref>, <xref ref-type="bibr" rid="B21">152</xref>]. In addition, such strains should be of human origin,resistant to acid and bile, and survive and be metabolically active within theintestinal lumen. Probiotics must also be antagonistic against pathogenicbacteria as they produce antimicrobial substances, compete within the GI tract,and promote a reduction in colonic pH.</p><p>Manyclinical trials have documented that probiotics can achieve and maintainremission in patients with ulcerative colitis, and also prevent and maintainremission of pouchitis. However,probiotics seem to be ineffective in Crohn's disease [<xref ref-type="bibr" rid="B26">153</xref>]. Although controlled clinical trials arestill required to investigate the unresolved issues related to efficacy, dose,duration of use, single or multistrain formulation, and simultaneous use ofprobiotics, synbiotics, or antibiotics, the preliminary data for thetherapeutic use of probiotics in selective patients with mild to moderate IBDare encouraging.</p></sec></body><back><ack><title>ACKNOWLEDGMENT</title><p>This report is supported by the National Institutes of Health, Grants DK56754 andDK33506 to B. A. McCormick.</p></ack><ref-list><ref id="B121"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>DC</given-names></name></person-group><article-title>Microbial ecology of the gastrointestinal tract</article-title><source><italic>Annual Review of Microbiology</italic></source><year>1977</year><volume>31</volume><fpage>107</fpage><lpage>133</lpage></citation></ref><ref id="B46"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Midwedt</surname><given-names>T</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>How host-microbial interactions shape the nutrient environment of the mammalian intestine</article-title><source><italic>Annual Review of Nutrition</italic></source><year>2002</year><volume>22</volume><fpage>283</fpage><lpage>307</lpage></citation></ref><ref id="B57"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelsall</surname><given-names>BL</given-names></name></person-group><article-title>Innate and adaptive mechanisms to control of pathological intestinal inflammation</article-title><source><italic>The Journal of Pathology</italic></source><year>2008</year><volume>214</volume><issue>2</issue><fpage>242</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">18161750</pub-id></citation></ref><ref id="B65"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Klein</surname><given-names>S</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>Microbial ecology: human gut microbes associated with obesity</article-title><source><italic>Nature</italic></source><year>2006</year><volume>444</volume><issue>7122</issue><fpage>1022</fpage><lpage>1023</lpage><pub-id pub-id-type="pmid">17183309</pub-id></citation></ref><ref id="B134"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Mahowald</surname><given-names>MA</given-names></name><name><surname>Magrini</surname><given-names>V</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title><source><italic>Nature</italic></source><year>2006</year><volume>444</volume><issue>7122</issue><fpage>1027</fpage><lpage>1031</lpage><pub-id pub-id-type="pmid">17183312</pub-id></citation></ref><ref id="B19"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brugman</surname><given-names>S</given-names></name><name><surname>Klatter</surname><given-names>FA</given-names></name><name><surname>Visser</surname><given-names>JTJ</given-names></name><etal/></person-group><article-title>Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?</article-title><source><italic>Diabetologia</italic></source><year>2006</year><volume>49</volume><issue>9</issue><fpage>2105</fpage><lpage>2108</lpage><pub-id pub-id-type="pmid">16816951</pub-id></citation></ref><ref id="B32"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dumas</surname><given-names>M-E</given-names></name><name><surname>Barton</surname><given-names>RH</given-names></name><name><surname>Toye</surname><given-names>A</given-names></name><etal/></person-group><article-title>Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2006</year><volume>103</volume><issue>33</issue><fpage>12511</fpage><lpage>12516</lpage><pub-id pub-id-type="pmid">16895997</pub-id></citation></ref><ref id="B130"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strober</surname><given-names>W</given-names></name><name><surname>Fuss</surname><given-names>I</given-names></name><name><surname>Mannon</surname><given-names>P</given-names></name></person-group><article-title>The fundamental basis of inflammatory bowel disease</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>2007</year><volume>117</volume><issue>3</issue><fpage>514</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">17332878</pub-id></citation></ref><ref id="B27"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>F-F</given-names></name><name><surname>Esworthy</surname><given-names>RS</given-names></name><name><surname>Chu</surname><given-names>PG</given-names></name><etal/></person-group><article-title>Bacteria-induced intestinal cancer in mice with disrupted <italic>Gpx1</italic> and <italic>Gpx2</italic> genes</article-title><source><italic>Cancer Research</italic></source><year>2004</year><volume>64</volume><issue>3</issue><fpage>962</fpage><lpage>968</lpage><pub-id pub-id-type="pmid">14871826</pub-id></citation></ref><ref id="B96"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>JK</given-names></name><name><surname>Wilson</surname><given-names>ID</given-names></name></person-group><article-title>Understanding &#x02018;global&#x02019; systems biology: metabonomics and the continuum of metabolism</article-title><source><italic>Nature Reviews Drug Discovery</italic></source><year>2003</year><volume>2</volume><issue>8</issue><fpage>668</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">12904817</pub-id></citation></ref><ref id="B54"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Nicholson</surname><given-names>JK</given-names></name></person-group><article-title>Gut microbiota: a potential new territory for drug targeting</article-title><source><italic>Nature Reviews Drug Discovery</italic></source><year>2008</year><volume>7</volume><issue>2</issue><fpage>123</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">18239669</pub-id></citation></ref><ref id="B48"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Falk</surname><given-names>PG</given-names></name><name><surname>Midtvedt</surname><given-names>T</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1999</year><volume>96</volume><issue>17</issue><fpage>9833</fpage><lpage>9838</lpage><pub-id pub-id-type="pmid">10449780</pub-id></citation></ref><ref id="B69"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>TT</given-names></name><name><surname>Monteleone</surname><given-names>G</given-names></name></person-group><article-title>Immunity, inflammation, and allergy in the gut</article-title><source><italic>Science</italic></source><year>2005</year><volume>307</volume><issue>5717</issue><fpage>1920</fpage><lpage>1925</lpage><pub-id pub-id-type="pmid">15790845</pub-id></citation></ref><ref id="B20"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bry</surname><given-names>L</given-names></name><name><surname>Falk</surname><given-names>PG</given-names></name><name><surname>Midtvedt</surname><given-names>T</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>A model of host-microbial interactions in an open mammalian ecosystem</article-title><source><italic>Science</italic></source><year>1996</year><volume>273</volume><issue>5280</issue><fpage>1380</fpage><lpage>1383</lpage><pub-id pub-id-type="pmid">8703071</pub-id></citation></ref><ref id="B45"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>Commensal host-bacterial relationships in the gut</article-title><source><italic>Science</italic></source><year>2001</year><volume>292</volume><issue>5519</issue><fpage>1115</fpage><lpage>1118</lpage><pub-id pub-id-type="pmid">11352068</pub-id></citation></ref><ref id="B88"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moreau</surname><given-names>M-C</given-names></name><name><surname>Gaboriau-Routhiau</surname><given-names>V</given-names></name></person-group><article-title>The absence of gut flora, the doses of antigen ingested and aging affect the long-term peripheral tolerance induced by ovalbumin feeding in mice</article-title><source><italic>Research in Immunology</italic></source><year>1996</year><volume>147</volume><issue>1</issue><fpage>49</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">8739328</pub-id></citation></ref><ref id="B13"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>RD</given-names></name></person-group><article-title>The indigenous gastrointestinal microflora</article-title><source><italic>Trends in Microbiology</italic></source><year>1996</year><volume>4</volume><issue>11</issue><fpage>430</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">8950812</pub-id></citation></ref><ref id="B104"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Holzman</surname><given-names>IR</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name></person-group><article-title>Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier</article-title><source><italic>Pediatric Research</italic></source><year>2007</year><volume>61</volume><issue>1</issue><fpage>37</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">17211138</pub-id></citation></ref><ref id="B140"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Mahowald</surname><given-names>MA</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><etal/></person-group><article-title>Evolution of symbiotic bacteria in the distal human intestine</article-title><source><italic>PLoS Biology</italic></source><year>2007</year><volume>5</volume><issue>7</issue><fpage>1574</fpage><lpage>1586</lpage></citation></ref><ref id="B64"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Hamady</surname><given-names>M</given-names></name><name><surname>Lozupone</surname><given-names>C</given-names></name><etal/></person-group><article-title>Evolution of mammals and their gut microbes</article-title><source><italic>Science</italic></source><year>2008</year><volume>320</volume><issue>5883</issue><fpage>1647</fpage><lpage>1651</lpage><pub-id pub-id-type="pmid">18497261</pub-id></citation></ref><ref id="B72"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madara</surname><given-names>JL</given-names></name><name><surname>Parkos</surname><given-names>C</given-names></name><name><surname>Colgan</surname><given-names>S</given-names></name><name><surname>Nusrat</surname><given-names>A</given-names></name><name><surname>Atisook</surname><given-names>K</given-names></name><name><surname>Kaoutzani</surname><given-names>P</given-names></name></person-group><article-title>The movement of solutes and cells across tight junctions</article-title><source><italic>Annals of the New York Academy of Sciences</italic></source><year>1992</year><volume>664</volume><fpage>47</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">1456668</pub-id></citation></ref><ref id="B87"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mooseker</surname><given-names>MS</given-names></name></person-group><article-title>Organization, chemistry, and assembly of the cytoskeletal apparatus of the intestinal brush border</article-title><source><italic>Annual Review of Cell Biology</italic></source><year>1985</year><volume>1</volume><fpage>209</fpage><lpage>241</lpage></citation></ref><ref id="B124"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname><given-names>G</given-names></name></person-group><article-title>Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubuli</article-title><source><italic>Annual Review of Cell Biology</italic></source><year>1986</year><volume>2</volume><issue>1</issue><fpage>255</fpage><lpage>307</lpage></citation></ref><ref id="B51"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>S</given-names></name></person-group><article-title>Form and function of the glycocalyx on free cell surfaces</article-title><source><italic>Philosophical Transactions of the Royal Society of London. Series B</italic></source><year>1974</year><volume>268</volume><issue>891</issue><fpage>55</fpage><lpage>66</lpage></citation></ref><ref id="B76"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maury</surname><given-names>J</given-names></name><name><surname>Bernadac</surname><given-names>A</given-names></name><name><surname>Rigal</surname><given-names>A</given-names></name><name><surname>Maroux</surname><given-names>S</given-names></name></person-group><article-title>Expression and glycosylation of the filamentous brush border glycocalyx (FBBG) during rabbit enterocyte differentiation along the crypt-villus axis</article-title><source><italic>Journal of Cell Science</italic></source><year>1995</year><volume>108</volume><issue>7</issue><fpage>2705</fpage><lpage>2713</lpage><pub-id pub-id-type="pmid">7593311</pub-id></citation></ref><ref id="B77"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maury</surname><given-names>J</given-names></name><name><surname>Nicoletti</surname><given-names>C</given-names></name><name><surname>Guzzo-Chambraud</surname><given-names>L</given-names></name><name><surname>Maroux</surname><given-names>S</given-names></name></person-group><article-title>The filamentous brush border glycocalyx, a mucin-like marker of enterocyte hyper-polarization</article-title><source><italic>European Journal of Biochemistry</italic></source><year>1995</year><volume>228</volume><issue>2</issue><fpage>323</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">7535695</pub-id></citation></ref><ref id="B37"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>Y</given-names></name><name><surname>Owen</surname><given-names>RL</given-names></name></person-group><article-title>M cells as portals of infection: clinical and pathophysiological aspects</article-title><source><italic>Infectious Agents and Disease</italic></source><year>1996</year><volume>5</volume><issue>3</issue><fpage>144</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">8805077</pub-id></citation></ref><ref id="B95"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neutra</surname><given-names>MR</given-names></name><name><surname>Pringault</surname><given-names>E</given-names></name><name><surname>Kraehenbuhl</surname><given-names>J-P</given-names></name></person-group><article-title>Antigen sampling across epithelial barriers and induction of mucosal immune responses</article-title><source><italic>Annual Review of Immunology</italic></source><year>1996</year><volume>14</volume><fpage>275</fpage><lpage>300</lpage></citation></ref><ref id="B74"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantle</surname><given-names>M</given-names></name><name><surname>Basaraba</surname><given-names>L</given-names></name><name><surname>Peacock</surname><given-names>SC</given-names></name><name><surname>Gall</surname><given-names>DG</given-names></name></person-group><article-title>Binding of Yersinia enterocolitica to rabbit intestinal brush border membranes, mucus, and mucin</article-title><source><italic>Infection and Immunity</italic></source><year>1989</year><volume>57</volume><issue>11</issue><fpage>3292</fpage><lpage>3299</lpage><pub-id pub-id-type="pmid">2807525</pub-id></citation></ref><ref id="B25"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Baylor</surname><given-names>M</given-names></name><name><surname>Bass</surname><given-names>DM</given-names></name></person-group><article-title>Murine intestinal mucins inhibit rotavirus infection</article-title><source><italic>Gastroenterology</italic></source><year>1993</year><volume>105</volume><issue>1</issue><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">8390382</pub-id></citation></ref><ref id="B99"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nutten</surname><given-names>S</given-names></name><name><surname>Sansonetti</surname><given-names>P</given-names></name><name><surname>Huet</surname><given-names>G</given-names></name><etal/></person-group><article-title>Epithelial inflammation response induced by <italic>Shigella flexneri</italic> depends on mucin gene expression</article-title><source><italic>Microbes and Infection</italic></source><year>2002</year><volume>4</volume><issue>11</issue><fpage>1121</fpage><lpage>1124</lpage><pub-id pub-id-type="pmid">12361911</pub-id></citation></ref><ref id="B70"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname><given-names>DR</given-names></name><name><surname>Ahrne</surname><given-names>S</given-names></name><name><surname>Hyde</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Hollingsworth</surname><given-names>MA</given-names></name></person-group><article-title>Extracellular MUC3 mucin secretion follows adherence of <italic>Lactobacillus</italic> strains to intestinal epithelial cells in vitro</article-title><source><italic>Gut</italic></source><year>2003</year><volume>52</volume><issue>6</issue><fpage>827</fpage><lpage>833</lpage><pub-id pub-id-type="pmid">12740338</pub-id></citation></ref><ref id="B71"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname><given-names>DR</given-names></name><name><surname>Michail</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>McDougall</surname><given-names>L</given-names></name><name><surname>Hollingsworth</surname><given-names>MA</given-names></name></person-group><article-title>Probiotics inhibit enteropathogenic <italic>E. coli</italic> adherence in vitro by inducing intestinal mucin gene expression</article-title><source><italic>American Journal of Physiology</italic></source><year>1999</year><volume>276</volume><issue>4</issue><fpage>G941</fpage><lpage>G950</lpage><pub-id pub-id-type="pmid">10198338</pub-id></citation></ref><ref id="B127"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smirnova</surname><given-names>MG</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Birchall</surname><given-names>JP</given-names></name><name><surname>Pearson</surname><given-names>JP</given-names></name></person-group><article-title>LPS up-regulates mucin and cytokine mRNA expression and stimulates mucin and cytokine secretion in goblet cells</article-title><source><italic>Cellular Immunology</italic></source><year>2003</year><volume>221</volume><issue>1</issue><fpage>42</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">12742381</pub-id></citation></ref><ref id="B101"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ouellette</surname><given-names>AJ</given-names></name></person-group><article-title>Mucosal immunity and inflammation. IV. Paneth cell antimicrobial peptides and the biology of the mucosal barrier</article-title><source><italic>American Journal of Physiology</italic></source><year>1999</year><volume>277</volume><issue>2</issue><fpage>G257</fpage><lpage>G261</lpage><pub-id pub-id-type="pmid">10444437</pub-id></citation></ref><ref id="B143"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zasloff</surname><given-names>M</given-names></name></person-group><article-title>Antibiotic peptides as mediators of innate immunity</article-title><source><italic>Current Opinion in Immunology</italic></source><year>1992</year><volume>4</volume><issue>1</issue><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1596366</pub-id></citation></ref><ref id="B66"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li&#x000e9;vin-Le Moal</surname><given-names>V</given-names></name><name><surname>Servin</surname><given-names>AL</given-names></name></person-group><article-title>The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota</article-title><source><italic>Clinical Microbiology Reviews</italic></source><year>2006</year><volume>19</volume><issue>2</issue><fpage>315</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">16614252</pub-id></citation></ref><ref id="B34"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eckmann</surname><given-names>L</given-names></name></person-group><article-title>Defence molecules in intestinal innate immunity against bacterial infections</article-title><source><italic>Current Opinion in Gastroenterology</italic></source><year>2005</year><volume>21</volume><issue>2</issue><fpage>147</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">15711205</pub-id></citation></ref><ref id="B115"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salzman</surname><given-names>NH</given-names></name><name><surname>Ghosh</surname><given-names>D</given-names></name><name><surname>Huttner</surname><given-names>KM</given-names></name><name><surname>Paterson</surname><given-names>Y</given-names></name><name><surname>Bevins</surname><given-names>CL</given-names></name></person-group><article-title>Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin</article-title><source><italic>Nature</italic></source><year>2003</year><volume>422</volume><issue>6931</issue><fpage>522</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">12660734</pub-id></citation></ref><ref id="B106"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>EM</given-names></name><name><surname>van Dam</surname><given-names>E</given-names></name><name><surname>Valore</surname><given-names>EV</given-names></name><name><surname>Ganz</surname><given-names>T</given-names></name></person-group><article-title>Broad-spectrum antimicrobial activity of human intestinal defensin 5</article-title><source><italic>Infection and Immunity</italic></source><year>1997</year><volume>65</volume><issue>6</issue><fpage>2396</fpage><lpage>2401</lpage><pub-id pub-id-type="pmid">9169780</pub-id></citation></ref><ref id="B145"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wehkamp</surname><given-names>J</given-names></name><name><surname>Schauber</surname><given-names>J</given-names></name><name><surname>Stange</surname><given-names>EF</given-names></name></person-group><article-title>Defensins and cathelicidins in gastrointestinal infections</article-title><source><italic>Current Opinion in Gastroenterology</italic></source><year>2007</year><volume>23</volume><issue>1</issue><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">17133082</pub-id></citation></ref><ref id="B146"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pazgier</surname><given-names>M</given-names></name><name><surname>Hoover</surname><given-names>DM</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Lubkowski</surname><given-names>J</given-names></name></person-group><article-title>Human <italic>&#x003b2;</italic>-defensins</article-title><source><italic>Cellular and Molecular Life Sciences</italic></source><year>2006</year><volume>63</volume><issue>11</issue><fpage>1294</fpage><lpage>1313</lpage><pub-id pub-id-type="pmid">16710608</pub-id></citation></ref><ref id="B147"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>J-RC</given-names></name><name><surname>Jaumann</surname><given-names>F</given-names></name><name><surname>Schulz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Identification of a novel, multifunctional <italic>&#x003b2;</italic>-defensin (human <italic>&#x003b2;</italic>-defensin 3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction</article-title><source><italic>Cell and Tissue Research</italic></source><year>2001</year><volume>306</volume><issue>2</issue><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">11702237</pub-id></citation></ref><ref id="B148"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>J-RC</given-names></name><name><surname>Krause</surname><given-names>A</given-names></name><name><surname>Schulz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Human <italic>&#x003b2;</italic>-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity</article-title><source><italic>The FASEB Journal</italic></source><year>2001</year><volume>15</volume><issue>10</issue><fpage>1819</fpage><lpage>1821</lpage><pub-id pub-id-type="pmid">11481241</pub-id></citation></ref><ref id="B149"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Neil</surname><given-names>DA</given-names></name><name><surname>Porter</surname><given-names>EM</given-names></name><name><surname>Elewaut</surname><given-names>D</given-names></name><etal/></person-group><article-title>Expression and regulation of the human <italic>&#x003b2;</italic>-defensins hBD-1 and hBD-2 in intestinal epithelium</article-title><source><italic>The Journal of Immunology</italic></source><year>1999</year><volume>163</volume><issue>12</issue><fpage>6718</fpage><lpage>6724</lpage><pub-id pub-id-type="pmid">10586069</pub-id></citation></ref><ref id="B150"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Wada</surname><given-names>A</given-names></name><name><surname>Ogushi</surname><given-names>K-I</given-names></name><etal/></person-group><article-title>Production of <italic>&#x003b2;</italic>-defensin-2 by human colonic epithelial cells induced by <italic>Salmonella enteritidis</italic> flagella filament structural protein</article-title><source><italic>FEBS Letters</italic></source><year>2001</year><volume>508</volume><issue>3</issue><fpage>484</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">11728477</pub-id></citation></ref><ref id="B110"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenberger</surname><given-names>CM</given-names></name><name><surname>Gallo</surname><given-names>RL</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group><article-title>Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular <italic>Salmonella</italic> replication</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2004</year><volume>101</volume><issue>8</issue><fpage>2422</fpage><lpage>2427</lpage><pub-id pub-id-type="pmid">14983025</pub-id></citation></ref><ref id="B151"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bals</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>JM</given-names></name></person-group><article-title>Cathelicidins&#x02014;a family of multifunctional antimicrobial peptides</article-title><source><italic>Cellular and Molecular Life Sciences</italic></source><year>2003</year><volume>60</volume><issue>4</issue><fpage>711</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">12785718</pub-id></citation></ref><ref id="B47"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Stappenbeck</surname><given-names>TS</given-names></name><name><surname>Hong</surname><given-names>CV</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>Angiogenins: a new class of microbicidal proteins involved in innate immunity</article-title><source><italic>Nature Immunology</italic></source><year>2003</year><volume>4</volume><issue>3</issue><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">12548285</pub-id></citation></ref><ref id="B97"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nissen-Meyer</surname><given-names>J</given-names></name><name><surname>Nes</surname><given-names>IF</given-names></name></person-group><article-title>Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action</article-title><source><italic>Archives of Microbiology</italic></source><year>1997</year><volume>167</volume><issue>2-3</issue><fpage>67</fpage><lpage>77</lpage></citation></ref><ref id="B152"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganz</surname><given-names>T</given-names></name></person-group><article-title>Angiogenin: an antimicrobial ribonuclease</article-title><source><italic>Nature Immunology</italic></source><year>2003</year><volume>4</volume><issue>3</issue><fpage>213</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">12605229</pub-id></citation></ref><ref id="B24"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cash</surname><given-names>HL</given-names></name><name><surname>Whitham</surname><given-names>CV</given-names></name><name><surname>Behrendt</surname><given-names>CL</given-names></name><name><surname>Hooper</surname><given-names>LV</given-names></name></person-group><article-title>Symbiotic bacteria direct expression of an intestinal bactericidal lectin</article-title><source><italic>Science</italic></source><year>2006</year><volume>313</volume><issue>5790</issue><fpage>1126</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">16931762</pub-id></citation></ref><ref id="B17"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brandl</surname><given-names>K</given-names></name><name><surname>Plitas</surname><given-names>G</given-names></name><name><surname>Schnabl</surname><given-names>B</given-names></name><name><surname>DeMatteo</surname><given-names>RP</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name></person-group><article-title>MyD88-mediated signals induce the bactericidal lectin RegIII<italic>&#x003b3;</italic> and protect mice against intestinal <italic>Listeria monocytogenes</italic> infection</article-title><source><italic>The Journal of Experimental Medicine</italic></source><year>2007</year><volume>204</volume><issue>8</issue><fpage>1891</fpage><lpage>1900</lpage><pub-id pub-id-type="pmid">17635956</pub-id></citation></ref><ref id="B153"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keilbaugh</surname><given-names>SA</given-names></name><name><surname>Shin</surname><given-names>ME</given-names></name><name><surname>Banchereau</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Activation of RegIII<italic>&#x003b2;</italic>/<italic>&#x003b3;</italic> and interferon <italic>&#x003b3;</italic> expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut</article-title><source><italic>Gut</italic></source><year>2005</year><volume>54</volume><issue>5</issue><fpage>623</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">15831905</pub-id></citation></ref><ref id="B138"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>SH</given-names></name><name><surname>Wimley</surname><given-names>WC</given-names></name><name><surname>Selsted</surname><given-names>ME</given-names></name></person-group><article-title>Structure, function, and membrane integration of defensins</article-title><source><italic>Current Opinion in Structural Biology</italic></source><year>1995</year><volume>5</volume><issue>4</issue><fpage>521</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">8528769</pub-id></citation></ref><ref id="B63"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lehrer</surname><given-names>RI</given-names></name><name><surname>Ganz</surname><given-names>T</given-names></name></person-group><article-title>Cathelicidins: a family of endogenous antimicrobial peptides</article-title><source><italic>Current Opinion in Hematology</italic></source><year>2002</year><volume>9</volume><issue>1</issue><fpage>18</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">11753073</pub-id></citation></ref><ref id="B22"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cario</surname><given-names>E</given-names></name><name><surname>Gerken</surname><given-names>G</given-names></name><name><surname>Podolsky</surname><given-names>DK</given-names></name></person-group><article-title>&#x0201c;For whom the bell tolls!&#x0201d;&#x02014;innate defense mechanisms and survival strategies of the intestinal epithelium against lumenal pathogens</article-title><source><italic>Zeitschrift f&#x000fc;r Gastroenterologie</italic></source><year>2002</year><volume>40</volume><issue>12</issue><fpage>983</fpage><lpage>990</lpage></citation></ref><ref id="B23"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cario</surname><given-names>E</given-names></name><name><surname>Podolsky</surname><given-names>DK</given-names></name></person-group><article-title>Intestinal epithelial TOLLerance versus inTOLLerance of commensals</article-title><source><italic>Molecular Immunology</italic></source><year>2005</year><volume>42</volume><issue>8</issue><fpage>887</fpage><lpage>893</lpage><pub-id pub-id-type="pmid">15829278</pub-id></citation></ref><ref id="B52"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janeway</surname><given-names>CA</given-names><suffix>Jr.</suffix></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><article-title>Innate immune recognition</article-title><source><italic>Annual Review of Immunology</italic></source><year>2002</year><volume>20</volume><fpage>197</fpage><lpage>216</lpage></citation></ref><ref id="B53"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janssens</surname><given-names>S</given-names></name><name><surname>Beyaert</surname><given-names>R</given-names></name></person-group><article-title>Role of Toll-like receptors in pathogen recognition</article-title><source><italic>Clinical Microbiology Reviews</italic></source><year>2003</year><volume>16</volume><issue>4</issue><fpage>637</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">14557290</pub-id></citation></ref><ref id="B55"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><article-title>Toll-like receptor downstream signaling</article-title><source><italic>Arthritis Research &#x00026; Therapy</italic></source><year>2005</year><volume>7</volume><issue>1</issue><fpage>12</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">15642149</pub-id></citation></ref><ref id="B93"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>van der Graaf</surname><given-names>C</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name></person-group><article-title>Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system</article-title><source><italic>Journal of Leukocyte Biology</italic></source><year>2004</year><volume>75</volume><issue>5</issue><fpage>749</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">15075354</pub-id></citation></ref><ref id="B105"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Philpott</surname><given-names>DJ</given-names></name><name><surname>Girardin</surname><given-names>SE</given-names></name></person-group><article-title>The role of Toll-like receptors and Nod proteins in bacterial infection</article-title><source><italic>Molecular Immunology</italic></source><year>2004</year><volume>41</volume><issue>11</issue><fpage>1099</fpage><lpage>1108</lpage><pub-id pub-id-type="pmid">15476921</pub-id></citation></ref><ref id="B1"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abreu</surname><given-names>MT</given-names></name></person-group><article-title>Nod2 in normal and abnormal intestinal immune function</article-title><source><italic>Gastroenterology</italic></source><year>2005</year><volume>129</volume><issue>4</issue><fpage>1302</fpage><lpage>1304</lpage><pub-id pub-id-type="pmid">16230083</pub-id></citation></ref><ref id="B112"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabroe</surname><given-names>I</given-names></name><name><surname>Parker</surname><given-names>LC</given-names></name><name><surname>Dower</surname><given-names>SK</given-names></name><name><surname>Whyte</surname><given-names>MKB</given-names></name></person-group><article-title>The role of TLR activation in inflammation</article-title><source><italic>The Journal of Pathology</italic></source><year>2008</year><volume>214</volume><issue>2</issue><fpage>126</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">18161748</pub-id></citation></ref><ref id="B141"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Ting</surname><given-names>JP-Y</given-names></name></person-group><article-title>NLR, the nucleotide-binding domain leucine-rich repeat containing gene family</article-title><source><italic>Current Opinion in Immunology</italic></source><year>2008</year><volume>20</volume><issue>1</issue><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18280719</pub-id></citation></ref><ref id="B109"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rietdijk</surname><given-names>ST</given-names></name><name><surname>Burwell</surname><given-names>T</given-names></name><name><surname>Bertin</surname><given-names>J</given-names></name><name><surname>Coyle</surname><given-names>AJ</given-names></name></person-group><article-title>Sensing intracellular pathogens-NOD-like receptors</article-title><source><italic>Current Opinion in Pharmacology</italic></source><year>2008</year><volume>8</volume><issue>3</issue><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">18487086</pub-id></citation></ref><ref id="B2"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abreu</surname><given-names>MT</given-names></name><name><surname>Vora</surname><given-names>P</given-names></name><name><surname>Faure</surname><given-names>E</given-names></name><name><surname>Thomas</surname><given-names>LS</given-names></name><name><surname>Arnold</surname><given-names>ET</given-names></name><name><surname>Arditi</surname><given-names>M</given-names></name></person-group><article-title>Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide</article-title><source><italic>The Journal of Immunology</italic></source><year>2001</year><volume>167</volume><issue>3</issue><fpage>1609</fpage><lpage>1616</lpage><pub-id pub-id-type="pmid">11466383</pub-id></citation></ref><ref id="B86"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melmed</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>LS</given-names></name><name><surname>Lee</surname><given-names>N</given-names></name><etal/></person-group><article-title>Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut</article-title><source><italic>The Journal of Immunology</italic></source><year>2003</year><volume>170</volume><issue>3</issue><fpage>1406</fpage><lpage>1415</lpage><pub-id pub-id-type="pmid">12538701</pub-id></citation></ref><ref id="B39"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gewirtz</surname><given-names>AT</given-names></name><name><surname>Navas</surname><given-names>TA</given-names></name><name><surname>Lyons</surname><given-names>S</given-names></name><name><surname>Godowski</surname><given-names>PJ</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name></person-group><article-title>Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression</article-title><source><italic>The Journal of Immunology</italic></source><year>2001</year><volume>167</volume><issue>4</issue><fpage>1882</fpage><lpage>1885</lpage><pub-id pub-id-type="pmid">11489966</pub-id></citation></ref><ref id="B85"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><article-title>Recognition of microorganisms and activation of the immune response</article-title><source><italic>Nature</italic></source><year>2007</year><volume>449</volume><issue>7164</issue><fpage>819</fpage><lpage>826</lpage><pub-id pub-id-type="pmid">17943118</pub-id></citation></ref><ref id="B10"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>JM</given-names></name><name><surname>Akerlund</surname><given-names>J</given-names></name><name><surname>Mittge</surname><given-names>E</given-names></name><name><surname>Guillemin</surname><given-names>K</given-names></name></person-group><article-title>Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota</article-title><source><italic>Cell Host &#x00026; Microbe</italic></source><year>2007</year><volume>2</volume><issue>6</issue><fpage>371</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">18078689</pub-id></citation></ref><ref id="B92"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neish</surname><given-names>AS</given-names></name><name><surname>Gewirtz</surname><given-names>AT</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><etal/></person-group><article-title>Prokaryotic regulation of epithelial responses by inhibition of I<italic>&#x003ba;</italic>B-<italic>&#x003b1;</italic> ubiquitination</article-title><source><italic>Science</italic></source><year>2000</year><volume>289</volume><issue>5484</issue><fpage>1560</fpage><lpage>1563</lpage><pub-id pub-id-type="pmid">10968793</pub-id></citation></ref><ref id="B139"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winston</surname><given-names>JT</given-names></name><name><surname>Strack</surname><given-names>P</given-names></name><name><surname>Beer-Romero</surname><given-names>P</given-names></name><name><surname>Chu</surname><given-names>CY</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name><name><surname>Harper</surname><given-names>JW</given-names></name></person-group><article-title>The SCF<sup><italic>&#x003b2;</italic><sup>-TRCP</sup></sup>-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in I<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic> and <italic>&#x003b2;</italic>-catenin and stimulates I<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic> ubiquitination in vitro</article-title><source><italic>Genes &#x00026; Development</italic></source><year>1999</year><volume>13</volume><issue>3</issue><fpage>270</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">9990852</pub-id></citation></ref><ref id="B100"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohh</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>WY</given-names></name><name><surname>Moslehi</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells</article-title><source><italic>EMBO Reports</italic></source><year>2002</year><volume>3</volume><issue>2</issue><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">11818338</pub-id></citation></ref><ref id="B107"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Read</surname><given-names>MA</given-names></name><name><surname>Brownell</surname><given-names>JE</given-names></name><name><surname>Gladysheva</surname><given-names>TB</given-names></name><etal/></person-group><article-title>Nedd8 modification of Cul-1 activates SCF<sup><italic>&#x003b2;</italic><sup>Trcp</sup></sup>-dependent ubiquitination of I<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic></article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2000</year><volume>20</volume><issue>7</issue><fpage>2326</fpage><lpage>2333</lpage><pub-id pub-id-type="pmid">10713156</pub-id></citation></ref><ref id="B28"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collier-Hyams</surname><given-names>LS</given-names></name><name><surname>Sloane</surname><given-names>V</given-names></name><name><surname>Batten</surname><given-names>BC</given-names></name><name><surname>Neish</surname><given-names>AS</given-names></name></person-group><article-title>Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1</article-title><source><italic>The Journal of Immunology</italic></source><year>2005</year><volume>175</volume><issue>7</issue><fpage>4194</fpage><lpage>4198</lpage><pub-id pub-id-type="pmid">16177058</pub-id></citation></ref><ref id="B122"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schauer</surname><given-names>DB</given-names></name></person-group><article-title>Indigenous microflora: paving the way for pathogens?</article-title><source><italic>Current Biology</italic></source><year>1997</year><volume>7</volume><issue>2</issue><fpage>R75</fpage><lpage>R77</lpage><pub-id pub-id-type="pmid">9081667</pub-id></citation></ref><ref id="B38"><label>79</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gal&#x000e1;n</surname><given-names>JE</given-names></name><name><surname>Wolf-Watz</surname><given-names>H</given-names></name></person-group><article-title>Protein delivery into eukaryotic cells by type III secretion machines</article-title><source><italic>Nature</italic></source><year>2006</year><volume>444</volume><issue>7119</issue><fpage>567</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">17136086</pub-id></citation></ref><ref id="B50"><label>80</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hueck</surname><given-names>CJ</given-names></name></person-group><article-title>Type III protein secretion systems in bacterial pathogens of animals and plants</article-title><source><italic>Microbiology and Molecular Biology Reviews</italic></source><year>1998</year><volume>62</volume><issue>2</issue><fpage>379</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">9618447</pub-id></citation></ref><ref id="B144"><label>81</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Gal&#x000e1;n</surname><given-names>JE</given-names></name></person-group><article-title>						<italic>Salmonella</italic> entry into host cells: the work in concert of type III secreted effector proteins</article-title><source><italic>Microbes and Infection</italic></source><year>2001</year><volume>3</volume><issue>14-15</issue><fpage>1293</fpage><lpage>1298</lpage><pub-id pub-id-type="pmid">11755417</pub-id></citation></ref><ref id="B123"><label>82</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sears</surname><given-names>CL</given-names></name></person-group><article-title>Molecular physiology and pathophysiology of tight junctions. V. Assault of the tight junction by enteric pathogens</article-title><source><italic>American Journal of Physiology</italic></source><year>2000</year><volume>279</volume><issue>6</issue><fpage>G1129</fpage><lpage>G1134</lpage><pub-id pub-id-type="pmid">11093933</pub-id></citation></ref><ref id="B43"><label>83</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hecht</surname><given-names>G</given-names></name><name><surname>Koutsouris</surname><given-names>A</given-names></name><name><surname>Pothoulakis</surname><given-names>C</given-names></name><name><surname>LaMont</surname><given-names>JT</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name></person-group><article-title>Clostridium difficile toxin B disrupts the barrier function of T84 monolayers</article-title><source><italic>Gastroenterology</italic></source><year>1992</year><volume>102</volume><issue>2</issue><fpage>416</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">1732112</pub-id></citation></ref><ref id="B142"><label>84</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuhan</surname><given-names>R</given-names></name><name><surname>Koutsouris</surname><given-names>A</given-names></name><name><surname>Savkovlc</surname><given-names>SD</given-names></name><name><surname>Hecht</surname><given-names>G</given-names></name></person-group><article-title>Enteropathogenic <italic>Escherichia coli</italic>-induced myosin light chain phosphorylation alters intestinal epithelial permeability</article-title><source><italic>Gastroenterology</italic></source><year>1997</year><volume>113</volume><issue>6</issue><fpage>1873</fpage><lpage>1882</lpage><pub-id pub-id-type="pmid">9394726</pub-id></citation></ref><ref id="B58"><label>85</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;hler</surname><given-names>H</given-names></name><name><surname>Sakaguchi</surname><given-names>T</given-names></name><name><surname>Hurley</surname><given-names>BP</given-names></name><name><surname>Kase</surname><given-names>BJ</given-names></name><name><surname>Reinecker</surname><given-names>H-C</given-names></name><name><surname>McCormick</surname><given-names>BA</given-names></name></person-group><article-title>						<italic>Salmonella enterica</italic> serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage</article-title><source><italic>American Journal of Physiology</italic></source><year>2007</year><volume>293</volume><issue>1</issue><fpage>G178</fpage><lpage>G187</lpage><pub-id pub-id-type="pmid">17615177</pub-id></citation></ref><ref id="B108"><label>86</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Resta-Lenert</surname><given-names>S</given-names></name><name><surname>Barrett</surname><given-names>KE</given-names></name></person-group><article-title>Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2</article-title><source><italic>Gastroenterology</italic></source><year>2002</year><volume>122</volume><issue>4</issue><fpage>1070</fpage><lpage>1087</lpage><pub-id pub-id-type="pmid">11910358</pub-id></citation></ref><ref id="B15"><label>87</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertelsen</surname><given-names>LS</given-names></name><name><surname>Paesold</surname><given-names>G</given-names></name><name><surname>Marcus</surname><given-names>SL</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name><name><surname>Eckmann</surname><given-names>L</given-names></name><name><surname>Barrett</surname><given-names>KE</given-names></name></person-group><article-title>Modulation of chloride secretory responses and barrier function of intestinal epithelial cells by the <italic>Salmonella</italic> effector protein SigD</article-title><source><italic>American Journal of Physiology</italic></source><year>2004</year><volume>287</volume><issue>4</issue><fpage>C939</fpage><lpage>C948</lpage><pub-id pub-id-type="pmid">15175224</pub-id></citation></ref><ref id="B16"><label>88</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>EC</given-names></name><name><surname>Brown</surname><given-names>NF</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group><article-title>						<italic>Salmonella enterica</italic> serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function</article-title><source><italic>Cellular Microbiology</italic></source><year>2006</year><volume>8</volume><issue>12</issue><fpage>1946</fpage><lpage>1957</lpage><pub-id pub-id-type="pmid">16869830</pub-id></citation></ref><ref id="B133"><label>89</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tafazoli</surname><given-names>F</given-names></name><name><surname>Magnusson</surname><given-names>K-E</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name></person-group><article-title>Disruption of epithelial barrier integrity by <italic>Salmonella enterica</italic> serovar Typhimurium requires geranylgeranylated proteins</article-title><source><italic>Infection and Immunity</italic></source><year>2003</year><volume>71</volume><issue>2</issue><fpage>872</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">12540569</pub-id></citation></ref><ref id="B89"><label>90</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mounier</surname><given-names>J</given-names></name><name><surname>Vasselon</surname><given-names>T</given-names></name><name><surname>Hellio</surname><given-names>R</given-names></name><name><surname>Lesourd</surname><given-names>M</given-names></name><name><surname>Sansonetti</surname><given-names>PJ</given-names></name></person-group><article-title>						<italic>Shigella flexneri</italic> enters human colonic Caco-2 epithelial cells through the basolateral pole</article-title><source><italic>Infection and Immunity</italic></source><year>1992</year><volume>60</volume><issue>1</issue><fpage>237</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">1729185</pub-id></citation></ref><ref id="B116"><label>91</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sansonetti</surname><given-names>P</given-names></name><name><surname>Phalipon</surname><given-names>A</given-names></name></person-group><article-title>Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development</article-title><source><italic>Research in Immunology</italic></source><year>1996</year><volume>147</volume><issue>8-9</issue><fpage>595</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">9127893</pub-id></citation></ref><ref id="B114"><label>92</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>T</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>H</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>McCormick</surname><given-names>BA</given-names></name><name><surname>Reinecker</surname><given-names>H-C</given-names></name></person-group><article-title>						<italic>Shigella flexneri</italic> regulates tight junction-associated proteins in human intestinal epithelial cells</article-title><source><italic>Cellular Microbiology</italic></source><year>2002</year><volume>4</volume><issue>6</issue><fpage>367</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">12067320</pub-id></citation></ref><ref id="B35"><label>93</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>IM</given-names></name><name><surname>Silva</surname><given-names>M</given-names></name><name><surname>Schuch</surname><given-names>R</given-names></name><etal/></person-group><article-title>Cadaverine prevents the escape of <italic>Shigella flexneri</italic> from the phagolysosome: a connection between bacterial dissemination and neutrophil transepithelial signaling</article-title><source><italic>The Journal of Infectious Diseases</italic></source><year>2001</year><volume>184</volume><issue>6</issue><fpage>743</fpage><lpage>753</lpage><pub-id pub-id-type="pmid">11517436</pub-id></citation></ref><ref id="B14"><label>94</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernardini</surname><given-names>ML</given-names></name><name><surname>Mounier</surname><given-names>J</given-names></name><name><surname>d'Hauteville</surname><given-names>H</given-names></name><name><surname>Coquis-Rondon</surname><given-names>M</given-names></name><name><surname>Sansonetti</surname><given-names>PJ</given-names></name></person-group><article-title>Identification of <italic>icsA</italic>, a plasmid locus of <italic>Shigella flexneri</italic> that governs bacterial intra- and intercellular spread through interaction with F-actin</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1989</year><volume>86</volume><issue>10</issue><fpage>3867</fpage><lpage>3871</lpage><pub-id pub-id-type="pmid">2542950</pub-id></citation></ref><ref id="B118"><label>95</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sansonnetti</surname><given-names>PJ</given-names></name><name><surname>Kopecko</surname><given-names>DJ</given-names></name><name><surname>Formal</surname><given-names>SB</given-names></name></person-group><article-title>Involvement of a plasmid in the invasive ability of <italic>Shigella flexneri</italic></article-title><source><italic>Infection and Immunity</italic></source><year>1982</year><volume>35</volume><issue>3</issue><fpage>852</fpage><lpage>860</lpage><pub-id pub-id-type="pmid">6279518</pub-id></citation></ref><ref id="B117"><label>96</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sansonetti</surname><given-names>PJ</given-names></name><name><surname>D'Hauteville</surname><given-names>H</given-names></name><name><surname>Ecobichon</surname><given-names>C</given-names></name><name><surname>Pourcel</surname><given-names>C</given-names></name></person-group><article-title>Molecular comparison of virulence plasmids in <italic>Shigella</italic> and enteroinvasive <italic>Escherichia coli</italic></article-title><source><italic>Annales de Microbiologie</italic></source><year>1983</year><volume>134A</volume><issue>3</issue><fpage>295</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">6357023</pub-id></citation></ref><ref id="B120"><label>97</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sasakawa</surname><given-names>C</given-names></name><name><surname>Komatsu</surname><given-names>K</given-names></name><name><surname>Tobe</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Yoshikawa</surname><given-names>M</given-names></name></person-group><article-title>Eight genes in region 5 that form an operon are essential for invasion of epithelial cells by <italic>Shigella flexneri </italic>2a</article-title><source><italic>Journal of Bacteriology</italic></source><year>1993</year><volume>175</volume><issue>8</issue><fpage>2334</fpage><lpage>2346</lpage><pub-id pub-id-type="pmid">8385666</pub-id></citation></ref><ref id="B111"><label>98</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rout</surname><given-names>WR</given-names></name><name><surname>Formal</surname><given-names>SB</given-names></name><name><surname>Dammin</surname><given-names>GJ</given-names></name><name><surname>Giannella</surname><given-names>RA</given-names></name></person-group><article-title>Pathophysiology of <italic>Salmonella diarrhea</italic> in the Rhesus monkey: intestinal transport, morphological and bacteriological studies</article-title><source><italic>Gastroenterology</italic></source><year>1974</year><volume>67</volume><issue>1</issue><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">4210000</pub-id></citation></ref><ref id="B42"><label>99</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hecht</surname><given-names>G</given-names></name></person-group><article-title>Innate mechanisms of epithelial host defense: spotlight on intestine</article-title><source><italic>American Journal of Physiology</italic></source><year>1999</year><volume>277</volume><issue>3</issue><fpage>C351</fpage><lpage>C358</lpage><pub-id pub-id-type="pmid">10484321</pub-id></citation></ref><ref id="B3"><label>100</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asakura</surname><given-names>H</given-names></name><name><surname>Yoshioka</surname><given-names>M</given-names></name></person-group><article-title>Cholera toxin and diarrhoea</article-title><source><italic>Journal of Gastroenterology and Hepatology</italic></source><year>1994</year><volume>9</volume><issue>2</issue><fpage>186</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">8003653</pub-id></citation></ref><ref id="B128"><label>101</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spangler</surname><given-names>BD</given-names></name></person-group><article-title>Structure and function of cholera toxin and the related <italic>Escherichia coli</italic> heat-labile enterotoxin</article-title><source><italic>Microbiology and Molecular Biology Reviews</italic></source><year>1992</year><volume>56</volume><issue>4</issue><fpage>622</fpage><lpage>647</lpage></citation></ref><ref id="B102"><label>102</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parsot</surname><given-names>C</given-names></name><name><surname>Sansonetti</surname><given-names>PJ</given-names></name></person-group><article-title>Invasion and the pathogenesis of <italic>Shigella</italic> infections</article-title><source><italic>Current Topics in Microbiology and Immunology</italic></source><year>1996</year><volume>209</volume><fpage>25</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">8742244</pub-id></citation></ref><ref id="B12"><label>103</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benya</surname><given-names>RV</given-names></name><name><surname>Marrero</surname><given-names>JA</given-names></name><name><surname>Ostrovskiy</surname><given-names>DA</given-names></name><name><surname>Koutsouris</surname><given-names>A</given-names></name><name><surname>Hecht</surname><given-names>G</given-names></name></person-group><article-title>Human colonic epithelial cells express galanin-1 receptors, which when activated cause Cl<sup>&#x02212;</sup> secretion</article-title><source><italic>American Journal of Physiology</italic></source><year>1999</year><volume>276</volume><issue>1</issue><fpage>G64</fpage><lpage>G72</lpage><pub-id pub-id-type="pmid">9886980</pub-id></citation></ref><ref id="B67"><label>104</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lundgren</surname><given-names>O</given-names></name><name><surname>Peregrin</surname><given-names>AT</given-names></name><name><surname>Persson</surname><given-names>K</given-names></name><name><surname>Kordasti</surname><given-names>S</given-names></name><name><surname>Uhnoo</surname><given-names>I</given-names></name><name><surname>Svensson</surname><given-names>L</given-names></name></person-group><article-title>Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea</article-title><source><italic>Science</italic></source><year>2000</year><volume>287</volume><issue>5452</issue><fpage>491</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">10642552</pub-id></citation></ref><ref id="B135"><label>105</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turnbull</surname><given-names>PCB</given-names></name><name><surname>Richmond</surname><given-names>JE</given-names></name></person-group><article-title>A model of <italic>Salmonella</italic> enteritis: the behaviour of <italic>Salmonella enteritidis</italic> in chick intestine studied by light and electron microscopy</article-title><source><italic>British Journal of Experimental Pathology</italic></source><year>1978</year><volume>59</volume><issue>1</issue><fpage>64</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">346040</pub-id></citation></ref><ref id="B136"><label>106</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallis</surname><given-names>TS</given-names></name><name><surname>Hawker</surname><given-names>RJ</given-names></name><name><surname>Candy</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Quantification of the leucocyte influx into rabbit ileal loops induced by strains of <italic>Salmonella typhimurium</italic> of different virulence</article-title><source><italic>Journal of Medical Microbiology</italic></source><year>1989</year><volume>30</volume><issue>2</issue><fpage>149</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">2677382</pub-id></citation></ref><ref id="B82"><label>107</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>BA</given-names></name><name><surname>Hofman</surname><given-names>PM</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Carnes</surname><given-names>DK</given-names></name><name><surname>Miller</surname><given-names>SI</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name></person-group><article-title>Surface attachment of <italic>Salmonella typhimurium</italic> to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils</article-title><source><italic>The Journal of Cell Biology</italic></source><year>1995</year><volume>131</volume><issue>6, part 1</issue><fpage>1599</fpage><lpage>1608</lpage><pub-id pub-id-type="pmid">8522615</pub-id></citation></ref><ref id="B81"><label>108</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>BA</given-names></name><name><surname>Colgan</surname><given-names>SP</given-names></name><name><surname>Delp-Archer</surname><given-names>C</given-names></name><name><surname>Miller</surname><given-names>SI</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name></person-group><article-title>						<italic>Salmonella typhimurium</italic> attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils</article-title><source><italic>The Journal of Cell Biology</italic></source><year>1993</year><volume>123</volume><issue>4</issue><fpage>895</fpage><lpage>907</lpage><pub-id pub-id-type="pmid">8227148</pub-id></citation></ref><ref id="B60"><label>109</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kucharzik</surname><given-names>T</given-names></name><name><surname>Hudson</surname><given-names>JT</given-names><suffix>III</suffix></name><name><surname>L&#x000fc;gering</surname><given-names>A</given-names></name><etal/></person-group><article-title>Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury</article-title><source><italic>Gut</italic></source><year>2005</year><volume>54</volume><issue>11</issue><fpage>1565</fpage><lpage>1572</lpage><pub-id pub-id-type="pmid">15987794</pub-id></citation></ref><ref id="B84"><label>110</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>BA</given-names></name><name><surname>Parkos</surname><given-names>CA</given-names></name><name><surname>Colgan</surname><given-names>SP</given-names></name><name><surname>Carnes</surname><given-names>DK</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name></person-group><article-title>Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by <italic>Salmonella typhimurium</italic></article-title><source><italic>The Journal of Immunology</italic></source><year>1998</year><volume>160</volume><issue>1</issue><fpage>455</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">9552004</pub-id></citation></ref><ref id="B90"><label>111</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mrsny</surname><given-names>RJ</given-names></name><name><surname>Gewirtz</surname><given-names>AT</given-names></name><name><surname>Siccardi</surname><given-names>D</given-names></name><etal/></person-group><article-title>Identification of hepoxilin A<sub>3</sub> in inflammatory events: a required role in neutrophil migration across intestinal epithelia</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2004</year><volume>101</volume><issue>19</issue><fpage>7421</fpage><lpage>7426</lpage><pub-id pub-id-type="pmid">15123795</pub-id></citation></ref><ref id="B40"><label>112</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gewirtz</surname><given-names>AT</given-names></name><name><surname>Siber</surname><given-names>AM</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name><name><surname>McCormick</surname><given-names>BA</given-names></name></person-group><article-title>Orchestration of neutrophil movement by intestinal epithelial cells in response to <italic>Salmonella typhimurium</italic> can be uncoupled from bacterial internalization</article-title><source><italic>Infection and Immunity</italic></source><year>1999</year><volume>67</volume><issue>2</issue><fpage>608</fpage><lpage>617</lpage><pub-id pub-id-type="pmid">9916066</pub-id></citation></ref><ref id="B80"><label>113</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>BA</given-names></name></person-group><article-title>Bacterial-induced hepoxilin A<sub>3</sub> secretion as a proinflammatory mediator</article-title><source><italic>FEBS Journal</italic></source><year>2007</year><volume>274</volume><issue>14</issue><fpage>3513</fpage><lpage>3518</lpage><pub-id pub-id-type="pmid">17608718</pub-id></citation></ref><ref id="B83"><label>114</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>BA</given-names></name><name><surname>Miller</surname><given-names>SI</given-names></name><name><surname>Carnes</surname><given-names>D</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name></person-group><article-title>Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis</article-title><source><italic>Infection and Immunity</italic></source><year>1995</year><volume>63</volume><issue>6</issue><fpage>2302</fpage><lpage>2309</lpage><pub-id pub-id-type="pmid">7768613</pub-id></citation></ref><ref id="B91"><label>115</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nash</surname><given-names>S</given-names></name><name><surname>Stafford</surname><given-names>J</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name></person-group><article-title>Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>1987</year><volume>80</volume><issue>4</issue><fpage>1104</fpage><lpage>1113</lpage><pub-id pub-id-type="pmid">3116044</pub-id></citation></ref><ref id="B62"><label>116</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CA</given-names></name><name><surname>Silva</surname><given-names>M</given-names></name><name><surname>Siber</surname><given-names>AM</given-names></name><name><surname>Kelly</surname><given-names>AJ</given-names></name><name><surname>Galyov</surname><given-names>E</given-names></name><name><surname>McCormick</surname><given-names>BA</given-names></name></person-group><article-title>A secreted <italic>Salmonella</italic> protein induces a proinflammatory response in epithelial cells, which promotes neutrophil migration</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2000</year><volume>97</volume><issue>22</issue><fpage>12283</fpage><lpage>12288</lpage><pub-id pub-id-type="pmid">11050248</pub-id></citation></ref><ref id="B29"><label>117</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Criss</surname><given-names>AK</given-names></name><name><surname>Silva</surname><given-names>M</given-names></name><name><surname>Casanova</surname><given-names>JE</given-names></name><name><surname>McCormick</surname><given-names>BA</given-names></name></person-group><article-title>Regulation of <italic>Salmonella</italic>-induced neutrophil transmigration by epithelial ADP-ribosylation factor 6</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2001</year><volume>276</volume><issue>51</issue><fpage>48431</fpage><lpage>48439</lpage><pub-id pub-id-type="pmid">11641400</pub-id></citation></ref><ref id="B9"><label>118</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barthel</surname><given-names>M</given-names></name><name><surname>Hapfelmeier</surname><given-names>S</given-names></name><name><surname>Quintanilla-Mart&#x000ed;nez</surname><given-names>L</given-names></name><etal/></person-group><article-title>Pretreatment of mice with streptomycin provides a <italic>Salmonella enterica</italic> serovar Typhimurium colitis model that allows analysis of both pathogen and host</article-title><source><italic>Infection and Immunity</italic></source><year>2003</year><volume>71</volume><issue>5</issue><fpage>2839</fpage><lpage>2858</lpage><pub-id pub-id-type="pmid">12704158</pub-id></citation></ref><ref id="B8"><label>119</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrow</surname><given-names>PA</given-names></name><name><surname>Tucker</surname><given-names>JF</given-names></name></person-group><article-title>Inhibition of colonization of the chicken caecum with <italic>Salmonella typhimurium</italic> by pretreatment with strains of <italic>Escherichia coli</italic></article-title><source><italic>Journal of Hygiene</italic></source><year>1986</year><volume>96</volume><issue>2</issue><fpage>161</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">3517153</pub-id></citation></ref><ref id="B49"><label>120</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hudault</surname><given-names>S</given-names></name><name><surname>Guignot</surname><given-names>J</given-names></name><name><surname>Servin</surname><given-names>AL</given-names></name></person-group><article-title>						<italic>Escherichia coli</italic> strains colonising the gastrointestinal tract protect germfree mice against <italic>Salmonella typhimurium</italic> infection</article-title><source><italic>Gut</italic></source><year>2001</year><volume>49</volume><issue>1</issue><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">11413110</pub-id></citation></ref><ref id="B129"><label>121</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stecher</surname><given-names>B</given-names></name><name><surname>Robbiani</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>AW</given-names></name><etal/></person-group><article-title>						<italic>Salmonella enterica</italic> serovar Typhimurium exploits inflammation to compete with the intestinal microbiota</article-title><source><italic>PLoS Biology</italic></source><year>2007</year><volume>5</volume><issue>10</issue><fpage>2177</fpage><lpage>2189</lpage><pub-id pub-id-type="pmid">17760501</pub-id></citation></ref><ref id="B68"><label>122</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lupp</surname><given-names>C</given-names></name><name><surname>Robertson</surname><given-names>ML</given-names></name><name><surname>Wickham</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae</article-title><source><italic>Cell Host &#x00026; Microbe</italic></source><year>2007</year><volume>2</volume><issue>3</issue><fpage>p. 204</fpage></citation></ref><ref id="B5"><label>123</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balamurugan</surname><given-names>R</given-names></name><name><surname>Janardhan</surname><given-names>HP</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Raghava</surname><given-names>MV</given-names></name><name><surname>Muliyil</surname><given-names>J</given-names></name><name><surname>Ramakrishna</surname><given-names>BS</given-names></name></person-group><article-title>Molecular studies of fecal anaerobic commensal bacteria in acute diarrhea in children</article-title><source><italic>Journal of Pediatric Gastroenterology and Nutrition</italic></source><year>2008</year><volume>46</volume><issue>5</issue><fpage>514</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">18493205</pub-id></citation></ref><ref id="B61"><label>124</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lawley</surname><given-names>TD</given-names></name><name><surname>Bouley</surname><given-names>DM</given-names></name><name><surname>Hoy</surname><given-names>YE</given-names></name><name><surname>Gerke</surname><given-names>C</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name><name><surname>Monack</surname><given-names>DM</given-names></name></person-group><article-title>Host transmission of <italic>Salmonella enterica</italic> serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota</article-title><source><italic>Infection and Immunity</italic></source><year>2008</year><volume>76</volume><issue>1</issue><fpage>403</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">17967858</pub-id></citation></ref><ref id="B113"><label>125</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sahm</surname><given-names>DF</given-names></name><name><surname>Kissinger</surname><given-names>J</given-names></name><name><surname>Gilmore</surname><given-names>MS</given-names></name><etal/></person-group><article-title>In vitro susceptibility studies of vancomycin-resistant <italic>Enterococcus faecalis</italic></article-title><source><italic>Antimicrobial Agents and Chemotherapy</italic></source><year>1989</year><volume>33</volume><issue>9</issue><fpage>1588</fpage><lpage>1591</lpage><pub-id pub-id-type="pmid">2554802</pub-id></citation></ref><ref id="B103"><label>126</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paulsen</surname><given-names>IT</given-names></name><name><surname>Banerjei</surname><given-names>L</given-names></name><name><surname>Hyers</surname><given-names>GSA</given-names></name><etal/></person-group><article-title>Role of mobile DNA in the evolution of vancomycin-resistant <italic>Enterococcus faecalis</italic></article-title><source><italic>Science</italic></source><year>2003</year><volume>299</volume><issue>5615</issue><fpage>2071</fpage><lpage>2074</lpage><pub-id pub-id-type="pmid">12663927</pub-id></citation></ref><ref id="B56"><label>127</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>CP</given-names></name><name><surname>Pothoulakis</surname><given-names>C</given-names></name><name><surname>LaMont</surname><given-names>JT</given-names></name></person-group><article-title>Clostridium difficile colitis</article-title><source><italic>The New England Journal of Medicine</italic></source><year>1994</year><volume>330</volume><issue>4</issue><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">8043060</pub-id></citation></ref><ref id="B79"><label>128</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazmanian</surname><given-names>SK</given-names></name><name><surname>Round</surname><given-names>JL</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name></person-group><article-title>A microbial symbiosis factor prevents intestinal inflammatory disease</article-title><source><italic>Nature</italic></source><year>2008</year><volume>453</volume><issue>7195</issue><fpage>620</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">18509436</pub-id></citation></ref><ref id="B78"><label>129</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group><article-title>Capsular polysaccharides of symbiotic bacteria modulate immune responses during experimental colitis</article-title><source><italic>Journal of Pediatric Gastroenterology and Nutrition</italic></source><year>2008</year><volume>46</volume><issue>supplement 1</issue><fpage>E11</fpage><lpage>E12</lpage><pub-id pub-id-type="pmid">18354314</pub-id></citation></ref><ref id="B18"><label>130</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brubaker</surname><given-names>JO</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Tzianabos</surname><given-names>AO</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name><name><surname>Finberg</surname><given-names>RW</given-names></name></person-group><article-title>Mitogenic activity of purified capsular polysaccharide A from <italic>Bacteroides fragilis</italic>: differential stimulatory effect on mouse and rat lymphocytes in vitro</article-title><source><italic>The Journal of Immunology</italic></source><year>1999</year><volume>162</volume><issue>4</issue><fpage>2235</fpage><lpage>2242</lpage><pub-id pub-id-type="pmid">9973499</pub-id></citation></ref><ref id="B33"><label>131</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eckburg</surname><given-names>PB</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name></person-group><article-title>The role of microbes in Crohn's disease</article-title><source><italic>Clinical Infectious Diseases</italic></source><year>2007</year><volume>44</volume><issue>2</issue><fpage>256</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">17173227</pub-id></citation></ref><ref id="B36"><label>132</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>DN</given-names></name><name><surname>St Amand</surname><given-names>AL</given-names></name><name><surname>Feldman</surname><given-names>RA</given-names></name><name><surname>Boedeker</surname><given-names>EC</given-names></name><name><surname>Harpaz</surname><given-names>N</given-names></name><name><surname>Pace</surname><given-names>NR</given-names></name></person-group><article-title>Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2007</year><volume>104</volume><issue>34</issue><fpage>13780</fpage><lpage>13785</lpage><pub-id pub-id-type="pmid">17699621</pub-id></citation></ref><ref id="B11"><label>133</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baumgart</surname><given-names>M</given-names></name><name><surname>Dogan</surname><given-names>B</given-names></name><name><surname>Rishniw</surname><given-names>M</given-names></name><etal/></person-group><article-title>Culture independent analysis of ileal mucosa reveals a selective increase in invasive <italic>Escherichia coli</italic> of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum</article-title><source><italic>The ISME Journal</italic></source><year>2007</year><volume>1</volume><issue>5</issue><fpage>403</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">18043660</pub-id></citation></ref><ref id="B73"><label>134</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manichanh</surname><given-names>C</given-names></name><name><surname>Rigottier-Gois</surname><given-names>L</given-names></name><name><surname>Bonnaud</surname><given-names>E</given-names></name><etal/></person-group><article-title>Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach</article-title><source><italic>Gut</italic></source><year>2006</year><volume>55</volume><issue>2</issue><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">16188921</pub-id></citation></ref><ref id="B75"><label>135</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Medina</surname><given-names>M</given-names></name><name><surname>Aldeguer</surname><given-names>X</given-names></name><name><surname>Gonzalez-Huix</surname><given-names>F</given-names></name><name><surname>Acero</surname><given-names>D</given-names></name><name><surname>Garcia-Gil</surname><given-names>LJ</given-names></name></person-group><article-title>Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis</article-title><source><italic>Inflammatory Bowel Diseases</italic></source><year>2006</year><volume>12</volume><issue>12</issue><fpage>1136</fpage><lpage>1145</lpage><pub-id pub-id-type="pmid">17119388</pub-id></citation></ref><ref id="B131"><label>136</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swidsinski</surname><given-names>A</given-names></name><name><surname>Ladhoff</surname><given-names>A</given-names></name><name><surname>Pernthaler</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mucosal flora in inflammatory bowel disease</article-title><source><italic>Gastroenterology</italic></source><year>2002</year><volume>122</volume><issue>1</issue><fpage>44</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">11781279</pub-id></citation></ref><ref id="B119"><label>137</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sartor</surname><given-names>RB</given-names></name></person-group><article-title>Microbial influences in inflammatory bowel diseases</article-title><source><italic>Gastroenterology</italic></source><year>2008</year><volume>134</volume><issue>2</issue><fpage>577</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">18242222</pub-id></citation></ref><ref id="B132"><label>138</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swidsinski</surname><given-names>A</given-names></name><name><surname>Loening-Baucke</surname><given-names>V</given-names></name><name><surname>Theissig</surname><given-names>F</given-names></name><etal/></person-group><article-title>Comparative study of the intestinal mucus barrier in normal and inflamed colon</article-title><source><italic>Gut</italic></source><year>2007</year><volume>56</volume><issue>3</issue><fpage>343</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">16908512</pub-id></citation></ref><ref id="B7"><label>139</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnich</surname><given-names>N</given-names></name><name><surname>Darfeuille-Michaud</surname><given-names>A</given-names></name></person-group><article-title>Adherent-invasive <italic>Escherichia coli</italic> and Crohn's disease</article-title><source><italic>Current Opinion in Gastroenterology</italic></source><year>2007</year><volume>23</volume><issue>1</issue><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">17133079</pub-id></citation></ref><ref id="B30"><label>140</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darfeuille-Michaud</surname><given-names>A</given-names></name><name><surname>Boudeau</surname><given-names>J</given-names></name><name><surname>Bulois</surname><given-names>P</given-names></name><etal/></person-group><article-title>High prevalence of adherent-invasive <italic>Escherichia coli</italic> associated with ileal mucosa in Crohn's disease</article-title><source><italic>Gastroenterology</italic></source><year>2004</year><volume>127</volume><issue>2</issue><fpage>412</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">15300573</pub-id></citation></ref><ref id="B94"><label>141</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neut</surname><given-names>C</given-names></name><name><surname>Bulois</surname><given-names>P</given-names></name><name><surname>Desreumaux</surname><given-names>P</given-names></name><etal/></person-group><article-title>Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease</article-title><source><italic>The American Journal of Gastroenterology</italic></source><year>2002</year><volume>97</volume><issue>4</issue><fpage>939</fpage><lpage>946</lpage><pub-id pub-id-type="pmid">12003430</pub-id></citation></ref><ref id="B6"><label>142</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnich</surname><given-names>N</given-names></name><name><surname>Carvalho</surname><given-names>FA</given-names></name><name><surname>Glasser</surname><given-names>A-L</given-names></name><etal/></person-group><article-title>CEACAM6 acts as a receptor for adherent-invasive <italic>E. coli</italic>, supporting ileal mucosa colonization in Crohn disease</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>2007</year><volume>117</volume><issue>6</issue><fpage>1566</fpage><lpage>1574</lpage><pub-id pub-id-type="pmid">17525800</pub-id></citation></ref><ref id="B59"><label>143</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korzenik</surname><given-names>JR</given-names></name></person-group><article-title>Is Crohn's disease due to defective immunity?</article-title><source><italic>Gut</italic></source><year>2007</year><volume>56</volume><issue>1</issue><fpage>2</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17172582</pub-id></citation></ref><ref id="B137"><label>144</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wehkamp</surname><given-names>J</given-names></name><name><surname>Salzman</surname><given-names>NH</given-names></name><name><surname>Porter</surname><given-names>E</given-names></name><etal/></person-group><article-title>Reduced Paneth cell <italic>&#x003b1;</italic>-defensins in ileal Crohn's disease</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2005</year><volume>102</volume><issue>50</issue><fpage>18129</fpage><lpage>18134</lpage><pub-id pub-id-type="pmid">16330776</pub-id></citation></ref><ref id="B98"><label>145</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nuding</surname><given-names>S</given-names></name><name><surname>Fellermann</surname><given-names>K</given-names></name><name><surname>Wehkamp</surname><given-names>J</given-names></name><name><surname>Stange</surname><given-names>EF</given-names></name></person-group><article-title>Reduced mucosal antimicrobial activity in Crohn's disease of the colon</article-title><source><italic>Gut</italic></source><year>2007</year><volume>56</volume><issue>9</issue><fpage>1240</fpage><lpage>1247</lpage><pub-id pub-id-type="pmid">17456510</pub-id></citation></ref><ref id="B44"><label>146</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hisamatsu</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Reinecker</surname><given-names>H-C</given-names></name><name><surname>Nadeau</surname><given-names>WJ</given-names></name><name><surname>McCormick</surname><given-names>BA</given-names></name><name><surname>Podolsky</surname><given-names>DK</given-names></name></person-group><article-title>CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells</article-title><source><italic>Gastroenterology</italic></source><year>2003</year><volume>124</volume><issue>4</issue><fpage>993</fpage><lpage>1000</lpage><pub-id pub-id-type="pmid">12671896</pub-id></citation></ref><ref id="B125"><label>147</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shanahan</surname><given-names>F</given-names></name></person-group><article-title>Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics</article-title><source><italic>Gastroenterology</italic></source><year>2001</year><volume>120</volume><issue>3</issue><fpage>622</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">11179240</pub-id></citation></ref><ref id="B126"><label>148</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shanahan</surname><given-names>F</given-names></name></person-group><article-title>Probiotics in inflamatory bowel disease</article-title><source><italic>Gut</italic></source><year>2001</year><volume>48</volume><issue>5</issue><fpage>p. 609</fpage></citation></ref><ref id="B41"><label>149</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gionchetti</surname><given-names>P</given-names></name><name><surname>Rizzello</surname><given-names>F</given-names></name><name><surname>Lammers</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Antibiotics and probiotics in treatment of inflammatory bowel disease</article-title><source><italic>World Journal of Gastroenterology</italic></source><year>2006</year><volume>12</volume><issue>21</issue><fpage>3306</fpage><lpage>3313</lpage><pub-id pub-id-type="pmid">16733845</pub-id></citation></ref><ref id="B4"><label>150</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>A-P</given-names></name><name><surname>Ouyang</surname><given-names>Q</given-names></name></person-group><article-title>Probiotics and inflammatory bowel diseases</article-title><source><italic>Postgraduate Medical Journal</italic></source><year>2006</year><volume>82</volume><issue>968</issue><fpage>376</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">16754706</pub-id></citation></ref><ref id="B31"><label>151</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dotan</surname><given-names>I</given-names></name><name><surname>Rachmilewitz</surname><given-names>D</given-names></name></person-group><article-title>Probiotics in inflammatory bowel disease: possible mechanisms of action</article-title><source><italic>Current Opinion in Gastroenterology</italic></source><year>2005</year><volume>21</volume><issue>4</issue><fpage>426</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">15930982</pub-id></citation></ref><ref id="B21"><label>152</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campieri</surname><given-names>M</given-names></name><name><surname>Gionchetti</surname><given-names>P</given-names></name></person-group><article-title>Bacteria as the cause of ulcerative colitis</article-title><source><italic>Gut</italic></source><year>2001</year><volume>48</volume><issue>1</issue><fpage>132</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">11115835</pub-id></citation></ref><ref id="B26"><label>153</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chermesh</surname><given-names>I</given-names></name><name><surname>Eliakim</surname><given-names>R</given-names></name></person-group><article-title>Probiotics and the gastrointestinal tract: where are we in 2005?</article-title><source><italic>World Journal of Gastroenterology</italic></source><year>2006</year><volume>12</volume><issue>6</issue><fpage>853</fpage><lpage>857</lpage><pub-id pub-id-type="pmid">16521211</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="fig1" position="float"><label>Figure 1</label><caption><p>(a) Healthy epithelialsurface. A healthy intestinal epithelial surface acts as a physical and biochemicalbarrier with key features including theapical brush border, the mucus layer, the presence of antimicrobial peptides(blue black dots) in the lumen, the glycocalyx, and the epithelial tightjunctions. Also seen in the illustration are numerous commensal bacteria and adendritic cell sampling the lumen with its extended dendrites (yellow). (b) Key features of <italic>S. typhimurium</italic> infected epithelium. Suchhost pathogen interactions involve translocation of bacterial effectors (greencircles) into the epithelial cells, membrane ruffling, bacterial endocytosis,and SCV formation. Chemoatractants are secreted by the epithelial surface thatleads to PMN influx. SCV: Salmonella containing vacuole. (c) Intestinal epithelialsurface of an antibiotic-treated patient showing enrichment of a set ofantibiotic resistant members of the commensal microflora (light blue and brown)such as <italic>C. difficle</italic> and <italic>E. faecalis</italic>. The <italic>C. difficle</italic> proteins, TcdA and Tcdb (red circles) actintracellularly as glycosyltransferases and inhibit Rho, Rac, and Cdc42. Theeffect of these modifications lead to actin condensation, transcriptionalactivation of several genes and apoptosis. Other mechanisms that are triggeredinclude basolateral IL8 secretion, apical Hepoxillin A synthesis, and PMNinflux in the apical surface.</p></caption><graphic xlink:href="IPID2008-626827.001"/></fig><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>Antimicrobial peptides/proteins and their targets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Class</th><th align="center" rowspan="1" colspan="1">Examples</th><th align="center" rowspan="1" colspan="1">Expression</th><th align="center" rowspan="1" colspan="1">Action</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>&#x003b1;</italic>-defensin</td><td align="center" rowspan="1" colspan="1">HD-5,HD-6</td><td align="center" rowspan="1" colspan="1">Paneth cells</td><td align="center" rowspan="1" colspan="1"><italic>L. monocytogenes</italic></td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B34">38</xref>&#x02013;<xref ref-type="bibr" rid="B145">41</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>E. coli</italic></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>S. typhimurium</italic></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x003b2;</italic>-defensin </td><td align="center" rowspan="1" colspan="1">hBD-1 </td><td align="center" rowspan="1" colspan="1">IECs </td><td align="center" rowspan="1" colspan="1"><italic>P. aeruginosa</italic></td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B146">42</xref>&#x02013;<xref ref-type="bibr" rid="B150">46</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">hBD-2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>E. coli</italic></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>Candidaalbicans</italic></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cathelicidin </td><td align="center" rowspan="1" colspan="1">hLL37</td><td align="center" rowspan="1" colspan="1">IECs</td><td align="center" rowspan="1" colspan="1"><italic>Salmonella</italic></td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B110">47</xref>, <xref ref-type="bibr" rid="B151">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Angiogenin </td><td align="center" rowspan="1" colspan="1">Angiogenin-4</td><td align="center" rowspan="1" colspan="1">Paneth cells</td><td align="center" rowspan="1" colspan="1">Gram positive</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B47">49</xref>&#x02013;<xref ref-type="bibr" rid="B152">51</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Bacteria</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">C-type lectin </td><td align="center" rowspan="1" colspan="1">RegIII<italic>&#x003b3;</italic></td><td align="center" rowspan="1" colspan="1">IECs</td><td align="center" rowspan="1" colspan="1">Gram positive</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B24">52</xref>&#x02013;<xref ref-type="bibr" rid="B153">54</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Bacteria</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></floats-wrap></article>